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CHAPTER 1 
Introduction 
Although more than 50% of colon cancer patients undergoing 
laparoscopic or open surgical procedures have viable colon tumor cells free in 
the peritoneum, only ~1% of these patients experience wound implantation 
[1,2,3,4,5]. In addition, only a fraction of patients with apparently resectable colon 
cancer will go on to experience metastasis at a distant site, approximately 33%. It 
is known that both wound implantation and metastasis require cell adhesion to 
the extracellular matrix and/or endothelium followed by rapid proliferation. 
However, this information suggests that the great majority of tumor cells never 
adhere [6]. For patients in whom errant tumor cells do adhere, the consequences 
may be radical surgery or possibly death. This unfortunate paradigm emphasizes 
the need to study the mechanisms underlying the cell adhesion and proliferation 
processes.   
Previous studies have indicated that pressure stimulated adhesion is β1 
integrin dependent [7]. Integrins are heterodimeric receptors embedded in the 
cell membrane that are composed of an α and a β subunit that are involved in 
cytoskeletal attachment to the extracellular matrix [8]. Integrins have no catalytic 
activity; however, their location within the membrane gives them the opportunity 
to participate in bi-directional signaling [9]. The ligands for integrins are 
components of the extracellular matrix, including laminin and collagen. Signaling 
initiated through extracellular ligand binding and/or ligand-induced integrin 
clustering is termed “outside-in” signaling, and may induce changes in 
cytoskeletal organization, protein phosphorylation and gene expression. Integrin 
affinity and avidity may both be modulated through the activation of “inside-out” 
2 
  
cytoplasmic signaling events that cause conformational changes in the 
extracellular ligand-binding sites (affinity) and cytoskeletal induced integrin 
clustering (avidity) [10]. Mediation of these properties provides an internal control 
over cell adhesiveness. Integrin-dependent cell adhesion has been shown to 
regulate colorectal carcinoma organ-specific metastasis through both changes in 
surface expression and alterations in integrin affinity [11,12]. 
Once a cell attaches to the extracellular matrix, integrin clustering leads to 
autophosphorylation and activation of focal adhesion kinase at tyrosine 397. This 
phosphorylation promotes the activation of intracellular signaling cascades. The 
phosphorylation of focal adhesion kinase at tyrosine 397 creates a high affinity 
binding site for the SH2 domain of Src family members [13]. Src is recruited and 
phosphorylated and leads to further phosphorylation of focal adhesion kinase at 
tyrosines 576 and 577 [14]. The C-terminal region of focal adhesion kinase 
contains proline rich sequences that give other molecules, such as p130Cas , the 
ability to bind. The binding of these molecules lead to activation of Rac and Rho 
GTPases and influence cell migration and many other diverse cellular processes 
[15].   
In 2000, Basson et al. reported that colon cancer cells adhere to collagen 
and endothelial cells upon exposure to 15mmHg increased pressure for 30 
minutes. This result was confirmed in four colon cancer cell lines (SW620, Caco-
2, HT-29, SW1116), as well as primary tumor cells from 20 colon cancer patients 
[7]. These results are clinically relevant, as patients are exposed to increases in 
pressure during laparoscopic insufflation, surgical manipulation and post 
operative edema [16]. Furthermore, additional evidence indicated that increasing 
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pressure to the same extent caused breast cancer cell adhesion to collagen [17]. 
These results are also clinically relevant, as studies have shown that breast 
tumors can experience intratumoral pressures exceeding 29mmHg [18,19]. 
In contrast to “outside in” signaling that occurs upon ligand binding to 
integrin receptors, “inside out” signaling causes internal activation of signaling 
cascades. “Inside out” signaling is β1 integrin dependent and can be influenced 
by various cations [7,20]. Cellular adhesion occurs without increased surface 
expression of β1 integrin, which suggests that receptor affinity modulation may 
be responsible for the pressure effect [21]. SW620 cells exposed to elevated 
pressure that are unable to adhere show activation of focal adhesion kinase at 
tyrosine 397, as well as Src activation. In addition, inhibiting focal adhesion 
kinase by specific siRNA or inhibiting Src using PP2, completely abrogated the 
pressure effect [21]. Further studies confirmed that an intact cytoskeleton is 
necessary for pressure stimulated adhesion. When the cytoskeleton is 
compromised by agents including colchicines, phalloidin and cytochalasin D, the 
pressure effect is abolished. Using these inhibitors, it was determined that Src 
phosphorylation is cytoskeleton independent, as Src phosphorylation continues 
to take place in the presence of cytoskeletal inhibitors. Focal adhesion kinase, on 
the other hand, does not become phosphorylated in the presence of these 
inhibitors [22]. Recent data also shows that PI3 kinase inhibitors (LY294002 and 
wortmannin), siRNA treatment to reduce Akt, and Akt inhibitors each also block 
pressure stimulated cell adhesion in SW620 cells as well as human primary 
tumor cells. Pressure was shown to activate PI3 kinase and phosphorylate Akt. 
4 
  
Pressure also stimulates the relocation of focal adhesion kinase to the cell 
membrane, except in the presence of Akt inhibitor IV [23]. While several 
molecules have been identified in the pressure stimulated adhesion pathway, the 
overall mechanism is still poorly understood. Paxillin may prove to be important 
in this pathway, as it is involved in focal adhesion complex assembly and linkage 
of the focal adhesion complex to integrins and the cytoskeleton.   
Paxillin is a 68-kDa focal adhesion protein that has been implicated in 
diverse cellular events including cellular motility, cell spreading, embryogenesis, 
intracellular signaling pathways, and apoptosis [24]. Several types of cancer, 
including head and neck cancers and human osteosarcomas have shown 
increased paxillin expression relative to their normal counterparts [25]. Paxillin 
acts as a multi-domain adaptor protein that is found at the interface between the 
plasma membrane and the actin cytoskeleton. The carboxyl terminus of paxillin 
consists of four LIM domains arranged in tandem. The LIM3 domain is known to 
anchor paxillin to the plasma membrane, and though the exact mechanism is not 
entirely known, in vitro and in vivo co-precipitation studies have shown that 
paxillin co-precipitates with the cytoplasmic tail of β1 integrin [26]. The amino 
terminus of paxillin contains the SH2 and SH3 domains which may contain the 
binding site for Src, and lead to Src localization to focal adhesions. Focal 
adhesion kinase is known to phosphorylate paxillin at two main sites; tyrosine 31 
and tyrosine 118 [27]. Upon this phosphorylation by focal adhesion kinase, two 
functional SH2 binding sites are generated for members of the Crk family of 
adaptor proteins to bind. This complex of paxillin and a Crk creates a docking site 
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for another focal adhesion protein; p130Cas  [28]. This complex of paxillin, Crk and 
p130Cas has been shown to be necessary for integrin-mediated cell motility 
through activation of Rac and Rho family members [29,30].   
In addition to increasing cancer cell adhesion, Walsh et al illustrated that 
24 hours of increased pressure also induces colon cancer cell proliferation on 
fibronectin and collagen. This effect was observed beginning at six hours and 
continued for 24 hours. During this time, proliferation was increased 46% and the 
percentage of cells in S-phase was also elevated approximately 20% relative to 
cells that remained in ambient pressure conditions. In a manner similar to that 
observed when short term pressure stimulates adhesion, 24 hours of pressure 
increased phosphorylation of Src, MEK and p38. However, in contrast, Akt 
phosphorylation was not increased. Additional differences were observed when 
pharmacological inhibition of PI-3-kinase, actin depolymerization, Src, p38 and 
MEK did not abolish the effect of pressure on cellular proliferation. It was further 
determined that inhibition of protein kinase C was sufficient to abolish pressure 
stimulated proliferation [31].   
Protein kinase C is a family of enzymes that serve many diverse functions 
and are known to stay activated for extended periods of time. Protein kinase C 
regulates cellular functions such as adhesion, migration, and immune cell 
regulation. Some protein kinase C isoforms can also regulate NF-kB activation as 
well as cellular proliferation [32,33].   
NF-kB is a rapidly acting transcription factor that modulates gene 
transcription in cell-cycle regulation, apoptosis, and proliferation. NF-kB signaling 
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is complex, and can promote proliferation through increased expression of cell 
cycle regulators, or cell death through interactions with anti-apoptotic factors 
such as FLIP and TRAF1/2 [34]. NF-kB family members share a Rel homology 
domain in their N-terminus. However, RelA, RelB and c-Rel are the only 
members with transactivation domains. NF-kB family members form homodimers 
or heterodimers to participate in transactivation. RelA, the p65 subunit, regulates 
transcription directly, as it has a nuclear translocation sequence in addition to a 
direct DNA binding site. Traditional NF-kB signaling involves heterodimerization 
between RelA and p50. NF-kB can promote or inhibit apoptosis depending upon 
the stimulus [35].     
Aberrant or constitutive NF-kB activation characterizes many human 
malignancies and indicates poor prognosis in colorectal and esophageal cancers 
[34,36,37]. Additionally, other studies have found that NF-kB immunoreactivity of 
correlates with poor prognosis in various cancers [38].   
Based on these previous observations, we hypothesized that paxillin, 
protein kinase C and NF-kB may be necessary molecules in the cellular signaling 
that occurs as pressure stimulates adhesion or proliferation. We assessed the 
role of these molecules in various cancer cell lines and further evaluated the 
effect of pressure on distant metastasis using an in vivo murine model. These 
pathways may represent a target of opportunity to inhibit adhesion and 
metastasis, as well as slow the growth of unresectable tumors or tumors not 
candidates for conventional cytotoxics.  
 
7 
  
CHAPTER 2 
Materials and Methods 
Cell Culture.  For initial characterization of CARP-1, estrogen receptor-
negative, p53 negative MDA-MB-468 human breast cancer cells were used. 
These cells were cultured and maintained using Dulbecco’s modified Eagle 
medium, Ham’s F-12 medium and fetal bovine serum. All studies involving 
CARP-1 utilized these cells. SW620 and Caco-2 colon cancer cell lines, MCF-7 
breast cancer and PC3 prostate cancer cell lines were obtained from the 
American Type Culture collection (Rockville, MD), and cultured according to the 
manufacture’s recommendation. The luciferase-tagged CT-26 murine colon 
cancer cell line (Caliper Life Sciences, Hopkinton, MA) was cultured using 600 
µg/mL geneticin. Primary human colon cancer cells were obtained from surgically 
resected specimens that were minced and collagenase digested into single cell 
suspensions. Viability of the isolated colonocytes was determined to be over 90% 
by trypan blue exclusion. The Wayne State University Human Investigation 
Committee approved the use of all human samples.   
Mice.  Balb/c mice were used for all in vivo tumor studies, as well as long 
term survival studies. All animal procedures were conducted with the approval of 
the Wayne State University Animal Investigation Committee and the John D. 
Dingell VA Medical Center Research and Development Committee.   
Pressure Regulation.  Pressure was regulated using an airtight Lucite 
box that was pre-warmed to 37°C to prevent internal fluctuations. The box 
contained an inlet and outlet valve for gas application and a manometer 
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connection, respectively. Temperature was regulated to within ± 2ºC and 
pressure was maintained to within 1.5 mmHg. Cells were placed in the pressure 
box from 30 minutes to 72 hours depending on the study under investigation. 
Ambient pressure control plates were placed in identical incubation conditions for 
the same duration of time.    
Pressure Measurements of Intraabdominal Malignant Tumors.  Under 
IRB-approved protocol, we measured interstitial pressure during image-guided 
biopsy just outside of 13 human tumors using a Transpac IV Monitoring Kit 
pressure transducer (Hospira, Lake Forest, IL) attached to a coaxial needle 
which was then advanced into the tumor for a second measurement. Pressure 
was measured during routine biopsies of tumors subsequently confirmed to be 
malignant but before removing biopsied tissue.     
Cell Adhesion Assay.  SW620 cells in suspension were placed in 
collagen I (Sigma, St. Louis, MO) pre-coated 6 well plates for 30 minutes under 
ambient or 15 mmHg increased pressure conditions in a 37°C incubator (10 5 
cells/well). After 30 minutes the non-adherent cells were washed away with 
phosphate buffered saline solution and the adherent cells were fixed with 
formalin and stained with hematoxylin. Each well was divided into 20 random, 
individual, high-power fields and cells were counted in each field using an 
inverted microscope[7].   
 To determine adhesion of SW620 cells that were transfected with the 
paxillin plasmid phosphorylation mutants or p130cas rescue plasmid, 48 hours 
post transfection the cells were plated in collagen I precoated 6 well plates as 
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described above. After 30 minutes of ambient or 15mmHg increased pressure, 
the non-adherent cells were washed away and the adherent cells were 
permeablized and incubated overnight with antibody to myc or human influenza 
hemagglutinin (HA) depending upon the tag of the mutant. After 24 hours, the 
myc or HA antibody was removed, the cells were washed with phosphate 
buffered saline solution and Texas Red (Amersham Pharmacia Biotech, 
Piscataway, NJ) was added for 1 hour. The cells were then counted under a 
fluorescence microscope.   
 Proliferation Assay.  5,000 cells per well were seeded in collagen I 
precoated 96-well plates. Various inhibitors were added at the concentrations 
listed in Table 1. Cells were exposed to increased or ambient pressure for 24 
hours. After 24 hours, MTT reagent was added and cells were incubated for 2-4 
hours at 37°C. Finally, the cells were treated with a detergent reagent overnight. 
The plates were then read on a fluorescence plate reader at 570 nm.   
Transfection.  For studies involving CARP-1, MDA-MB-468 human breast 
cancer cells were transfected with vector plasmids pcDNA3, pcDNA3/Hygro, 
pcDNA3/Hygro CARP-1 antisense clone 1.6, or pcDNA3/CARP-1-myc-His clone 
6.16. For stable transfections, this was followed by selection using 800 µg/mL of 
neomycin or 400 µg/mL of hygromycin. From this, multiple resistant stable sub-
lines were generated and propagated.   
Myc tagged wild type and Y31Y118 paxillin plasmid mutants were 
compliments of Dr. M. Cecilia Subauste. HA tagged wild type, as well as Y31, 
Y118, Y181 and Y31Y118Y181 paxillin plasmid mutants were generous gifts of 
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Dr. Ravi Salgia. All mutants had a Y F mutation on their respective tyrosine 
residues. Using Lipofectamine 2000 (Invitrogen, Carlsbad, CA), SW620 cells 
were transfected with 2 µg/ml of plasmids expressing myc tagged wild type or 
Y31Y118 mutant, or HA tagged wild type, Y31, Y118, Y181, or Y31Y118Y181 
mutants. 
 Additionally, total Crk, p130cas, α-actinin and FAK levels were reduced 
using small interfering RNA SMARTpools® produced by Dharmacon (Lafayette, 
CO), as well as oligofectamine and plus reagent according to the manufacturer’s 
protocol (Invitrogen, Carlsbad, CA). NF-kB p65 protein levels were reduced using 
NF-kB specific small interfering siRNA (Cell Signaling), as well as lipofectamine 
2000 (invitrogen) as recommended by the manufacture. Crk, p130cas and FAK 
expression was reduced using siRNA targeting the 5’- 
ACACTATTTGGACACTACA-3’ segment of Crk mRNA, the 5’- 
GGTCGACAGTGGTGTGTAT-3’ segment of p130cas mRNA and the 5’-
AAGCAUGUGGCCUGCUAUGGA-3’ segment of FAK mRNA. A Dharmacon 
siCONTROL® non-targeting siRNA #1 was used as a control. Scrambled siRNA 
sequences for paxillin, Crk and Cas were also used as a control.  The scrambled 
sequences used were:  paxillin 5’-TGGTGTCTTCCGTTTAGGG-3’, Crk 5’-
ATATAAGCAGCGTGATTCC-3’ and Cas 5’-CAGTGATGGTATGTGCGGT-3’.  All 
experiments were performed 48 hours post transfection.  
 Rac1 Activation Assay.  Rac1 activity was assessed using a pulldown 
assay (Millipore, Billerica, MA).  SW620 cells were grown to confluence and 
plated on dishes pre-coated with 1% heat inactivated BSA.  They were then 
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exposed to ambient or 15 mmHg increased pressure as described above.  Cells 
were collected by centrifugation and lysed using lysis buffer provided by the 
manufacturer.  Protein concentrations were determined by the BCA method.  
Active Rac1 levels were determined by GST-PBD (glutathione S-transferase-
conjugated p21 binding domain) of p21-activated kinase 1 pulldown assays.  The 
cell lysates were incubated with PAK-PBD beads for 1 hour at 4 °C on a rotator, 
and the beads were pelleted by centrifugation at 5000 x g for 2 min at 4 °C. The 
resulting pellet was then resuspended in Laemmli buffer resolved 
electrophoretically, transferred to nitrocellulose, and immunoblotted with 
monoclonal anti-Rac1 antibody (Pierce). Additionally, 20 µg of cell lysates were 
used for Western blotting for total Rac1. 
Inhibitor Studies.  The Src family kinase inhibitor PP2 (Calbiochem, 
Gibbstown, NJ) was dissolved in dimethyl sulfoxide (Me2SO) and diluted in cell 
culture medium immediately prior to use. SW620 cells were treated with 65 nM of 
PP2 or an equivalent amount of Me2SO (vehicle control) for 1 hour prior to 
adhesion or signaling studies. 30 nM of PP2 was added to cells for 24 hours 
during cellular proliferation studies and NF-kB activation studies. NSC23766 
(Calbiochem, Gibbstown, NJ), an inhibitor of Rac1 activation was dissolved in 
sterile distilled water and diluted in cell culture medium immediately prior to use. 
SW620 cells were treated with 50 µM NSC23766 or cell culture medium (vehicle 
control) for 1 hour prior to adhesion or signaling studies. 30 µM NSC23766 was 
added to the cells for 24 hours during cellular proliferation studies and NF-kB 
activation studies.   
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To further determine molecular signaling involved in pressure stimulated 
proliferation and NF-kB activation, selected inhibitors were dissolved in sterile 
phosphate buffered saline solution, dimethyl sulfoxide or water according to the 
manufacture’s protocol. Cells were treated with each inhibitor for 24 hours. Akt 
was inhibited using the 1 µM Akt inhibitor IV (EMD Chemicals, Gibbstown, NJ). 
NF-kB p50 nuclear localization was blocked with 12 µM SN50 (EMD Chemicals), 
in parallel with an SN50 inactive analog that does not affect NF-kB nuclear 
translocation. The NF-kB serine 276 inhibitory peptide (25 µM, Imgenex, San 
Diego, CA) acts as an NF-kB p65 nuclear decoy through phosphorylation at that 
site. Cells were treated with the inhibitory peptide of an inactive control. TCH-
021, a novel imidazoline inhibitor, was a generous gift from our collaborator, Dr. 
Jetze Tepe. It was used (5 µM) to inhibit NF-kB gene transcription by modulating 
IkB degradation and subsequently inhibiting NF-kB DNA binding.   
PKC was blocked globally using Calphostin C (100 nM). Inhibition of PKC-
α and PKC-β was achieved using Go6976 (6 nM). PKC-β alone was inhibited 
using 3-(1-(3-Imidazol-1-ylpropyl)-1H-indol-3-yl)-4-anilino-1H-pyrrole-2,5-dione 
(15 nM). Finally, the PKC-ε subunit was inhibited using a translocation inhibitory 
peptide (10 nM).   
To evaluate the role of the IKK complex subunits on pressure-stimulated 
proliferation, the IKK-2 inhibitor [5-(p-fluorophenyl)-2-ureido]-thiophene-3-
carboxamide (10 mM), IKK-3 inhibitor [5-(5,6-dimethoxybenzinidazol-1-yl)-3-(2-
methanesulfonyl-benzyloxy)-thiophene-2-carbonitrile] (40 nM) and the IKK 
inhibitor N-(6-chloro-9H-β-carbolin-8-yl)-nicotinamide (90 nM), that blocks IkB 
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phosphorylation, were used per manufacturer’s protocol, separately and in 
combination (EMD Chemicals). Table 1 lists all inhibitors used.   
Flow Cytometric Analysis.  To evaluate cellular proliferation, cells 
exposed to pressure for 24 hours were detached using trypsin/EDTA and fixed in 
90% ice cold ethanol. The cells were then stained with propidium iodide (5 µg/mL 
PBS, pH 7.4, containing 200 µg/mL DNase free Rnase A and 0.1% Triton-X 100). 
Transition to S-phase was evaluated using a FACSCalibur flow cytometer (BD 
Bioscience) and FlowJo software (Tree Star). Assays were performed on cells 
following 24 hours of serum starvation to induce cellular quiescence.   
To evaluate in vivo molecular signaling following cardiac puncture, 
isolated, CFSE labeled cells were fixed with 4% paraformaldehyde for 10 
minutes and washed with a staining buffer that contained 0.2% bovine serum 
albumin and 0.02% sodium azide in phosphate buffered saline. Cells were then 
incubated with anti-FAK, anti-Akt, and anti-mouse CD29 (9EG7) for 30 minutes 
at 4ºC.  Following antibody incubation, cells were washed twice with staining 
buffer and analyzed using the system and software stated above at the Wayne 
State University School of Medicine Flow Cytometry Core Facility.   
TUNEL Staining.  Cells were plated on collagen I pre-coated glass 
coverslips and exposed to increased or ambient pressure conditions for 24 
hours. Proteinase K digestion was performed followed by peroxidase blocking. 
Coverslips were incubated with TdT reaction buffer and reaction mixture and 
detected using streptavadin-HRP and DAB. Hematoxylin was used as a 
counterstain and the slides were coversliped using a xylene based mounting 
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medium. Apoptotic cells were counted on each slide and control and pressure 
treated cells were compared (TUNEL staining kit, Roche Applied Science, 
Indianapolis, IN).  
NF-kB Activity Assay.  Cellular NF-kB activity was assayed using a 
luciferase-based NF-kB lentiviral reporter assay (Qiagen, Frederick, MD). 5,000 
cells/well were plated in 96 well plates for 24 hours and lentiviral particles were 
introduced with SureENTRY transduction reagent (2 µg/mL, Qiagen) for 24 
hours. The lentiviral suspension was replaced with normal medium, and cells 
were exposed to ambient or increased pressure for 24 hours. Luciferin was 
added using the bright-glow luciferase assay (Promega, Madison, WI) and 
luminescence quantitated by a FLUOstar Omega plate reader (BMG LabTech, 
Offenburg, Germany).    
Nuclear Fractionation.  Cytosolic and nuclear fractions wee obtained 
using the Qproteome nuclear subfractionation kit (Qiagen).   
Immunoprecipitation and Western Blotting.  Signaling studies were 
performed on suspended cells that were plated on bacteriological dishes 
precoated with 1% heat inactivated bovine serum albumin to prevent adhesion. 
To study cellular signaling following 24 hours of pressure treatment, cells were 
grown on collagen I pre-coated tissue culture dishes. The cells were exposed to 
ambient or increased pressure for the desired time point and collected by 
centrifugation. A lysis buffer containing  50mM Tris pH 7.4, 150 mM NaCl, 1% 
Triton X-100, 10% glycerol, 1% deoxycholic acid, 0.1% SDS, 1mM EDTA, 1mM 
EGTA, 1mM PMSF, 1mM sodium vanadate, 50 mM NaF, 10mM sodium 
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pyrophosphate, 2 µg/mL aprotinin, and 2 µg/mL leupeptin was then used at 4°C. 
Total protein concentrations of the cell lysates were found using a bicinchoninic 
acid (BCA) protein assay kit (Pierce, Rockford, IL). For co-immunoprecipitation 
studies, 400µg of protein for each sample was incubated with its appropriate 
antibody for 1 hour, after which time agarose beads (Santa Cruz Biotechnology, 
Santa Cruz, CA) were added overnight. Proteins were resolved by sodium 
dodecyl sulfate polyacrylamide gel electrophoresis and transferred to a Hybound 
nitrocellulose membrane (Amersham Pharmacia Biotech). Mouse monoclonal 
antibodies to total paxillin, p130cas, Crk, total Rac (BD Transduction lab, San 
Diego, CA), GAPDH (Biodesign International, Saco, MN), actin (Sigma Aldrich), 
HA (Covance, Berkley, CA), cyclin D1, phospho-IkB, and myc (Cell Signaling, 
Beverly, MA), as well as rabbit polyclonal antibodies for CARP-1, total IkB 
(Sigma Aldrich), Histone H1 (Santa Cruz Biotechnology, Santa Cruz, CA), 
phospho-paxillin (pY31 – Biosource, Camarillo, CA; pY118 – Cell Signaling), 
phospho-FAK (Biosource), NF-kB p65 (Millipore, Billerica, MA), alpha-tubulin, 
phospho-IKKα/β, NF-kB p50 and phospho-Rac (Cell Signaling) were used for 
immunoprecipitation studies and/or protein detection along with the appropriate 
horseradish peroxidase – conjungated secondary antibodies. Antibodies are 
provided in an alphabetical listing in Table 2. Proteins were visualized by ECL-
Plus techniques (Amersham Pharmacia Biotech) and imaged and quantitated 
using a Kodak Phosphoimager (Perkin Elmer, Boston, MA). All blots were 
studied within the linear range of exposure.   
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NF-kB p50 and p65 Transcription Factor Activity.  NF-kB p50 and p65 
DNA binding activity was evaluated in nuclear lysates added to multi-well plates 
coated with the double stranded DNA consensus sequence by an ELISA based 
NF-kB p50 or p65 Transcription Factor Assay Kit (Cayman Chemical, Ann Arbor, 
MI).   
 In Vivo Splenic Injections.  Luciferase tagged CT-26 murine colon 
cancer cells were exposed to ambient or increased pressure for 30 minutes. 
Following pressure exposure, cells were collected by centrifugation and washed 
with sterile phosphate buffered saline solution. Balb/c mice were anesthetized 
with 60 mg/kg of intraperitoneal sodium pentobarbital and a small incision was 
made just above the spleen. Using a 30 gauge needle, one million cells were 
slowly injected into the spleen. The cavity was aspirated and closed using a 
suture or small animal wound clip.   
 For long term survival studies following splenic injections, mice were 
euthanized when visible internal tumor burden reached a maximum or when the 
mice became scruffy, lethargic or unable to take in food or water, as determined 
by DLAR personnel.  
 In Vivo Tail Vein Injection and Cardiac Puncture.  CT-26 murine colon 
cancer cells were labeled with CFSE for 30 minutes, collected by centrifugation 
and washed with sterile phosphate buffered saline solution. 1 million cells were 
injected into the tail vein of Balb/c mice. After 30 minutes, the mice were 
euthanized and cells were collected by injection of a 30 gauge needle into the left 
ventricle of the mouse. 1mL of heparin and 5 mL of red blood cell lysis buffer 
17 
  
were added to prevent blood clotting. The cellular suspension was centrifuged 
and the supernatant was discarded. The cellular pellet was used for further flow 
cytometric studies.   
 For long term survival studies following tail vein injections, mice were 
euthanized when visible internal tumor burden reached a maximum or when the 
mice became scruffy, lethargic or unable to take in food or water, as determined 
by DLAR personnel.  
 Bioluminescent Imaging of Metastasis.  10 days following splenic or tail 
vein injections, mice were re-anesthetized with 60 mg/kg of sodium pentobarbital 
and administered 150 mg/kg D-luciferin (BD Bioscience) intraperitoneally. After 
10 minutes, mice were assessed for relative CT-26 luciferase bioluminescence 
using a Kodak IS4000MM small animal imaging device over a 10 minute time 
period. Exposure conditions that include time, aperture, stage position, binning, 
and time after D-luciferin injection, were all held constant for each measurement. 
Bioluminescence intensity images were pseudo-colored (pink least intense and 
red most intense). All images were quantified using MetaMorph software 
(Universal Imaging Corp). Average image intensity was quantified using a fixed 
region of interest and calculated values were expressed as relative light units per 
minute (RLU).     
Active NF-kB, Cyclin D1 and IkB Immunohistochemistry in Human 
Tumors.  Under IRB-approved protocol, archived colon, lung and head and neck 
malignant tumors were sectioned, deparaffinized, steamed at 95°C with citrate 
antigen retrieval buffer (DAKO, Carpinteria, CA), rinsed with PBS and fixed with 
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3% hydrogen peroxide.  Non-specific staining was prevented by adding horse 
serum (Vector Laboratories, Burlingame, CA). The slides were rinsed and 
primary antibody to active NF-kB (Invitrogen), cyclin D1, or IkB was added at 
room temperature. After PBS-washing, slides were incubated with the 
biotinylated secondary antibody, streptavidin-peroxidase and amino-ethyl 
carbazol chromogen (VectaStain Universal Rapid Kit, Vector). Staining intensity 
was monitored to prevent overstaining. Slides were hematoxylin-counterstained 
and coverslipped using Geltol (ThermoShandon, Fisher Scientific, Hanover Park, 
IL).   
 A reviewer blinded to the study assigned scores from 0 (no 
immunostaining) to 4 (maximal immunostaining intensity) to the three areas 
under review; tumor center, tumor periphery and adjacent non-malignant tissue. 
Areas were determined based on proximity to non-malignant tissue, cell 
morphology and density. All areas of the slide that were able to be evaluated 
were evaluated.   
 Discernable mitotic figures were also counted in each area of the tumor 
periphery and center. Mitotic figures were also counted separately in tumor areas 
defined subjectively by a blinded reviewer as highly immunoreactive for active 
NF-kB or less immunoreactive for active NF-kB. All areas of the slide were 
counted for these studies.   
Statistical Analysis.  SigmaStat (SPSS Inc., Chicago, IL) was utilized for 
statistical analysis. Results were expressed as mean ± standard error. 
Differences between two groups were analyzed using Student’s t-test and 
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differences in immunostaining intensities were evaluated by chi-squared. 
Statistical significance was set at p<0.05.   
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Table 1.  Inhibitors 
 
Inhibitor   Target Concentration  Manufacture    Catalog 
             (Adhesion, Proliferation)         Number 
 
PP2       Src      65nM, 30nM     EMD Chemicals       529573 
 
NSC23766      Rac1     50uM, 30uM     EMD Chemicals     553502 
 
Akt Inh. IV          Akt      1uM      EMD Chemicals     124011 
 
SN50       NF-kB     12uM      EMD Chemicals      481480 
 
Serine 276      NF-kB     25uM      Imgenex       IMG-2001 
Inhibitory  
peptide 
 
TCH-021      NF-kB     5uM      Dr. Jetze Tepe      N/A 
 
Calphostin C      PKC    100nM      EMD Chemicals      UCN- 
               1028c 
 
Go6976      PKC α/β     6nM          EMD Chemicals      365250 
 
3-(1-(3-      PKC β    15nM      EMD Chemicals      539654 
Imidazol-1- 
ylpropyl)- 
1H-indol- 
3-yl)-4- 
anilino-1H- 
pyrrole-2,5- 
dione 
 
PKC-ε       PKC ε     10nM      EMD Chemicals     539522   
Inh.  
Peptide 
 
IKK-2 Inh.      IKK     10mM      EMD Chemicals     401481 
 
IKK-3 Inh.      IKK      40nM      EMD Chemicals     401488 
 
IKK 
Phospho-      IKK      90nM      EMD Chemicals     401489 
Inhibitor 
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Table 2.  Antibodies 
 
Antibody       Source       Manufacture       Catalog  
            Number 
 
     Actin  Mouse Sigma Aldrich   A3853 
 
      CARP-1  Rabbit  Sigma Aldrich   HPA007856 
 
      Crk  Mouse BD Biosciences   610035 
 
      Cyclin D1  Mouse  Cell Signaling   2922 
 
      FAK (phospho) Rabbit  Biosource     700255 
 
      GAPDH  Mouse  Biodesign Intl.   H86045M 
 
      HA   Mouse  Covance    MMS-101R 
 
      Histone H1 Rabbit  Santa Cruz    SC-10806 
 
      IkB (phospho) Mouse  Cell Signaling    9246 
 
      IkB (total)  Rabbit  Sigma Aldrich    I0505 
 
      IKK α/β  Rabbit  Cell Signaling    2681 
      (phospho) 
 
      Myc  Mouse  Cell Signaling    2278 
 
      NF-kB (p50) Rabbit  Cell Signaling    3035 
 
      NF-kB (p65) Rabbit  Millipore    AB1604 
 
      p130cas  Mouse  BD Biosciences   610271 
 
      Paxillin (total) Mouse  BD Biosciences    610568 
 
      Paxillin   Rabbit  Biosource     44720G 
      (phosphoY31) 
 
      Paxillin    Cell Signaling     2541 
      (phosphoY118) Rabbit   
 
      Rac1 (total) Mouse  BD Biosciences     610650 
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CHAPTER 3 
CARP-1 Modulation of Pressure-Induced Cancer Cell Adhesion 
 Malignant tumor cells in cancer patients undergoing surgical resection 
may be susceptible to extracellular forces such as increased pressure and shear 
stress during tumor manipulation or during passage through the venous and 
lymphatic system during dissemination. Tumor cells shed into a body cavity may 
also be exposed to pressure, shear, and turbulence during laparoscopic 
insufflation or irrigation, whereas intraabdominal pressure increases substantially 
for 2 to 3 days after surgery because of bowel edema and third spacing [1,5]. 
Previous studies suggest that increases in extracellular pressure, similar in 
magnitude to those observed in vivo in some surgical patients, stimulate the 
adhesion of colon cancer cells by a focal adhesion kinase (FAK)-dependent 
mechanism, but the other mediators of this pathway are poorly understood [7].   
 Interstitial fluid pressure in patients with invasive ductal carcinoma is 
increased compared with normal breast parenchyma and other malignant and 
nonmalignant conditions [18,19] by as much as 29 mmHg. We hypothesized that 
the adhesion of breast cancer cells might therefore be stimulated by extracellular 
pressure in a manner similar to that observed in colon cancer cells.   
 CARP-1/CCAR1 is a novel protein that has been implicated in cell-cycle 
and apoptosis regulation [39,40]. CARP-1 is a perinuclear/cytoplasmic 
transducer of apoptosis signaling that binds with stratifin/14-3-3 sigma. Depletion 
of CARP-1 inhibits apoptosis caused by agents such as adriamycin. Conversely, 
overexpression of CARP-1 increases apoptosis and reduces expression of 
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various cell-cycle regulators including c-myc and cyclin B. CARP-1 is expressed 
in a variety of cell types including human breast and colon cancer cells. Because 
CARP-1 regulates diverse intracellular signaling pathways, we hypothesized that 
CARP-1 levels influence pressure-stimulated cancer cell adhesion by modulating 
mediators of the pathways of cell adhesion and motility such as FAK [39].   
 We tested these hypotheses by studying MDA-MB-468 breast cancer cells 
in which CARP-1 expression was down-regulated or enhanced by stable 
expression of antisense or full-length complementary DNA (cDNA), respectively. 
We performed adhesion assays under conditions of ambient or 15 mmHg 
increased extracellular pressure and assessed CARP-1 levels, CARP-1-
dependent attenuation of FAK activation, and CARP-1 regulation of FAK by 
western blotting.   
 We previously performed various experiments involving different 
pressures and different time points and found that a 30-minute exposure to 
increased pressure was sufficient to both activate intracellular signals and 
enhance adhesion in colonic adenocarcinoma and other cancer cells [7]. We 
chose to replicate these conditions while evaluating CARP-1 in MDA-MB-468 
cells, both for consistency with our previous signal transduction work and 
because breast cancer cells are likely to experience a range of increased 
pressures up to 30 mmHg; 15 mmHg pressure increases therefore seem relevant 
to breast cancer patho-physiology.   
 We first sought to determine whether adhesion of MDA-MB-468 breast 
cancer cells increases in response to pressure because pressure effects on 
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breast cancer cells had not previously been shown. Single cell suspensions of 
several subclones of MDA-MB-468 breast cancer cells were allowed to adhere to 
type-I collagen for 30 minutes under ambient, 15 mmHg, or 30 mmHg increased 
pressure conditions before washing away nonadherent cells. Because the sub-
clones yielded similar results, data were pooled for analysis.  MDA-MD-468 
adhesion was increased by 25% ± 6% in response to 15 mmHg and 46% ± 9% in 
response to 30 mmHg increased pressure (Figure 1, n=3; p,0.05).   
 Because MDA-MB-468 breast cancer cells are known to express CARP-1 
and because FAK activation has previously been shown to mediate the effects of 
pressure on cancer cell adhesion, we sought initially to determine whether 
manipulating CARP-1 levels alters basal FAK activation. Cells were either 
untreated (wild type) or treated with retroviruses expressing wild-type CARP-1 for 
24 or 48 hours, followed by western blot analysis for expression of activated (p-
FAK) and native FAK proteins. FAK-397 phosphorylation was dramatically 
inhibited by CARP-1 overexpression (Figure 2, n=3; p<0.05).   
 Because pressure-stimulated MDA-MB-468 breast cancer cells adhesion 
and CARP-1 appeared to modulate FAK signaling, we created stable cell lines 
that overexpress CARP-1 or display decreased CARP-1 expression to 
investigate whether CARP-1 modulation would alter the adhesive response to 
pressure. We have previously characterized MDA-MB-468 subclones, stably 
transfected with antisense to CARP-1, which express approximately 50% less 
CARP-1 protein compared with the parental line. We chose 2 such subclones  
 
25 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  Effects of pressure on wild-type and vector-transfected cell 
adhesion.  Adhesion to type I collagen under ambient pressure conditions (open 
bars) was compared with adhesion under conditions of 15 mmHg increased 
pressure and again under conditions of 30 mmHg increased pressure (shaded 
bars) for 30 minutes.  At least 20 high-power fields were counted in each dish, 
and 3 separate dishes were studied in each experiment.  Adhesion data for each 
cell line were normalized to their respective ambient pressure controls before 
pooling data from 2 separate experiments with similar results (*P<0.05).   
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Figure 2.  Overexpression of CARP-1 leads to inhibition of FAK activity.  
FAK-397 phosphorylation was compared in wild-type parental cells (lane 1), cells 
that were transduced with viruses encoding CARP-1 (lanes 3 and 4, for a period 
of 24 and 48 hours, respectively).  Blots were stripped and reprobed for total FAK 
protein as a loading control.  FAK-397 phosphorylation was dramatically inhibited 
by CARP-1 overexpression.  Representative western blots are shown from 1 of 3 
similar studies.   
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and compared their adhesive response to pressure with 2 antisense-transfected 
subclones with normal CARP-1 expression.   
 Despite successful reduction of CARP-1, both cell lines expressing 
reduced CARP-1 continued to display pressure stimulated adhesion (Figure 3, 
n=16; p<0.05). Pressure stimulated adhesion in the antisense-transfected cells 
that did not express reduced CARP-1 was similar to both the parental line and 
the CARP-1 reduced cells.   
 Because reducing CARP-1 did not appear to modulate pressure 
stimulated adhesion, we performed similar studies after stably overexpressing 
CARP-1 (Figure 4, n=3; p<0.05). Adhesive responses to increased extracellular 
pressures in CARP-1 overexpressing cells were also similar to those observed in 
matched subclones from the same transfections that did not express CARP-1 
(Figure 5, n=16; p<0.05).   
 The regulation of cancer cell adhesion is an important phenomenon that 
may affect cancer metastasis in the perioperative period. Cell adhesion may be 
influenced by FAK signaling, and pressure stimulated adhesion is known to be 
mediated by FAK activation, but the mechanism by which this FAK signaling is 
activated by extracellular pressure is poorly understood [41]. Our data suggests 
that breast cancer cells display an increased adhesive response to extracellular 
pressure similar to that which we have previously described in colon cancer cells. 
Thus, the effect of extracellular pressure on cancer cell adhesion is not limited to 
colon cancers [41]. CARP-1 does modulate basal FAK signaling, but changes in  
 
28 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.  Reduction of CARP-1 does not alter pressure-stimulated 
adhesion.  Cell adhesion under ambient pressure conditions (open bars), was 
compared with adhesion under 15 mmHg increased pressure conditions (shaded 
bars) for an empty vector, as well as 2 MD-MBA-468 subclones that did not 
display CARP-1 reduction (clone 1.6 subline 1 and clone 1.6 subline 4; AS-1 and 
AS-4, respectively) and 2 subclones that displayed approximately 50% CARP-1 
reduction (clone 1.6 subline 9 and clone 1.6 subline 10; AS-9 and AS-10, 
respectively).  Each subclone displayed increased adhesion in response to 
extracellular pressure, independently of modulation of CARP-1 expression.  At 
least 20 high power fields were counted iin each dish, and 2 separate dishes 
were studied in each experiment.  Adhesion data for each cell line were 
normalized to their respective ambient pressure controls before pooling data from 
at least 8 separate experiments with similar results (*P<0.05).   
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Figure 4.  Overexpression of CARP-1.  Stable overexpression of CARP-1 is 
shown in MDA-MB-468 CARP-1 subline 4 in lane 1 compared with the parental 
MDA-MB-468 line in lane 2.  This figure depicts 1 of 3 similar western blots 
probed for the overexpressed myc-tagged transfectant with anti-myc antibody, for 
native CARP-1 itself with CARP-1 (α-2) antibody, and with α-tubulin as a protein 
loading control.   
 
 
 
 
 
 
30 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.  Overexpression of CARP-1 does not alter pressure-stimulated 
adhesion.  Cell adhesion under ambient pressure conditions (open bars) was 
compared with adhesion under 15 mmHg increased pressure conditions (shaded 
bars) for the MDA-MB-468 CARP-1 subline 4, which overexpresses CARP-1 and 
for MDA-MB-468 cells transfected with the empty vector alone.  Each subclone 
displayed increased adhesion in response to extracellular pressure, 
independently of modulation of CARP-1 expression.  At least 20 high power 
fields were counted in each dish, and 3 separate dishes were studied in each 
experiment.  Adhesion data for each cell line were normalized to their respective 
ambient pressure controls before pooling data from 2 separate experiments with 
similar results (*P<0.05).   
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CARP-1 expression does not affect the adhesive response to pressure, which 
suggests that CARP-1 is not involved in pressure stimulated adhesion.  
 Interstitial pressure is elevated in breast cancer patients undergoing 
needle biopsy [18]. In fact, increases in interstitial pressure seem to be a 
characteristic of rapidly growing breast cancers against their defining stroma. The 
activation of the adhesion of cancer cells by endogenous pressure within the 
tumor may affect the potential for metastasis both by increasing the incidence of 
local wound recurrence in the perioperative period, a complication requiring 
subsequent reoperation and mastectomy, or by increasing the metastatic 
potential of tumor cells as they pass through the lymphatics during dissemination 
even before surgical resection. Furthermore, when surgery is performed on 
breast cancer patients, even more pressure is exerted, which may cause a direct 
local effect specific to the perioperatiive period in which further pressure by 
surgical manipulation might cause shed tumor cells to adhere more efficiently. 
Thus, the pathway by which pressure stimulates adhesion may well be significant 
for breast cancer cells in vivo. We have previously shown that pressure 
stimulates colon cancer cell adhesion not only to purified matrix proteins but also 
to endothelial cell monolayers [41] and to surgical wounds in vivo [21].  
 Focal adhesion kinase (FAK) is a protein tyrosine kinase that is often 
overexpressed in cancer cells [41]. It is recruited to focal adhesions on the 
clustering of integrins through molecules such as talin or paxillin. FAK tyrosine 
397 is of particular interest because it rapidly undergoes autophosphorylation on 
cell adhesion to extracellular matrix proteins. This leaves a docking site for the 
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Src homology 2 domains of the Src family protein kinases that bind and further 
activate FAK, leading to association with PI3 kinase and activation of the MAP 
kinase cascade [42,43,44]. Previous studies have shown that pressure 
stimulates cell adhesion via FAK autophosphorylation of tyrosine 397. 
Conversely, blocking FAK signaling by transfection of a dominant negative FAK 
construct or reducing FAK by specific siRNA each prevent pressure stimulated 
adhesion in colon cancer cells [45,46]. Similar FAK signaling pathways seem to 
mediate pressure effects in various cell types. Our study extends these 
observations to breast cancer cells. Although FAK activation has not been 
specifically shown to mediate pressure stimulated adhesion in breast cancer cells 
in these studies, FAK may be similarly involved. Our results indicate that 
although CARP-1 does inhibit basal FAK tyrosine 397 phosphorylation, CARP-1 
overexpression does not appear to block the stimulation of FAK tyrosine 397 
phosphorylation by extracellular pressure or at least one downstream 
consequence; increased adhesion. This does not exclude the possibility that 
CARP-1 effects on FAK activation could still be important to other aspects of FAK 
signaling.   
 We have previously studied the effects of pressure on colon cancer cell 
apoptosis and anoikis [31]. Thus, pressure mediated FAK signaling might have 
other effects, with which CARP-1 might conceivably also interact. Such other 
potential effects of pressure in these cells await further study. CARP-1 is involved 
in apoptosis signaling pathways through interactions with the cytoplasmic protein 
14-3-3 [39]. Overexpression of CARP-1 inhibits cell growth regulatory proteins 
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such as c-myc. When CARP-1 was depleted, cell-cycle arrest and apoptosis 
signaling were altered [39,40]. Because CARP-1 modulates FAK signaling and 
FAK signaling is required for pressure stimulated adhesion, one would therefore 
similarly expect that modulation of CARP-1 would alter pressure stimulated 
adhesion. However, neither long term depletion nor overexpression of CARP-1 
impeded pressure stimulated adhesion in breast cancer cells. Furthermore, no 
significant changes in CARP-1 levels were noted after short-term exposure to 15 
mmHg increased pressure.   
 Our initial studies show that CARP-1 does modulate FAK activation in 
transient overexpression studies and raised the question of whether such a 
modulation might mediate pressure stimulated adhesion. The apparent 
dichotomy between the modulation of FAK in transient CARP-1 overexpression 
and the lack of effect of stable CARP-1 overexpression or underexpression might 
reflect adaptive processes to the chronic stable transfection. These might include 
compensatory modulation of other proteins that might interact with CARP-1, FAK 
or other proteins in the signal cascade. Indeed, database analyses recently 
revealed the presence of human deleted in breast cancer (DBC)-1 protein, which 
has significant homology to human CARP-1. Although CARP-1 and DBC-1 are 
encoded by separate genes located on chromosome 10 and 8, respectively, 
whether they possess overlapping or distinct functional domains and the extent 
to which DBC-1 may regulate signaling for pressure induced cell adhesion 
remain to be elucidated [39,40]. The characterization of such adaptations would 
be an interesting study in its own right, but our own results suffice to address our 
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initial hypothesis about CARP-1 because the stable transfection results strongly 
suggest that CARP-1 itself does not seem to modulate pressure stimulated 
adhesion. Alternatively, because CARP-1 modulates many other signal proteins 
besides FAK, the downstream effectors of CARP-1 may interact with the 
pressure pathway in other compensatory ways, co-modulating FAK signaling or 
reconstituting the pressure activated pathway downstream of FAK. Better 
understanding of how breast cancer cell pressure stimulated adhesion is 
reconstituted despite CARP-1 modulation therefore awaits delineation of the 
precise mechanism by which FAK itself modulates pressure stimulated adhesion 
in the future.   
 The results of this study do not exclude the possibility that CARP-1 may 
modulate other downstream consequences of FAK signaling. We studied the 
effects of inside out signaling in which intracellular signaling events triggered by 
increased extracellular pressure regulate integrin ligand binding function. 
However, FAK has been most frequently described as active in outside in 
signaling after cell adhesion, in which the occupancy of integrins by matrix 
ligands from outside the cell initiates signaling within the cell on ligand binding 
that then leads to downstream cellular consequences [41,46]. These results, 
therefore, do not exclude the possibility that CARP-1 modulation of FAK 
activation may influence outside-in signaling downstream of FAK, which is 
beyond the scope of our CARP-1/FAK study.   
 For the first time, we have shown that breast cancer cells do display 
pressure stimulated adhesion. This information may be important for 
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perioperative management to reduce local wound recurrence as well as for our 
ultimate understanding of the biology of these neoplasms. Because pressure 
also stimulates cancer cell proliferation [31], the proliferation of breast cancer 
cells within a constraining stroma may also be stimulated by extracellular 
pressure, causing a positive feedback cycle in which more rapidly proliferating 
tumors generate more pressure, which may cause increased proliferation. 
CARP-1 does inhibit FAK and could contribute to modulation of some of the 
signaling actions of this important kinase. Although the mechanisms by which 
breast cancer cells escape from CARP-1 modulation to continue to display 
pressure stimulated adhesion are unclear, our data suggests that CARP-1 
modulation may not be an attractive target for interventions designed to interfere 
with this potentially deleterious pressure activated pathway.    
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CHAPTER 4 
Role of Paxillin in Pressure-Induced Colon Cancer Cell Signaling 
 Paxillin is a 68 kDa focal adhesion associated protein that facilitates 
protein – protein interactions, focal adhesion assembly and functions in cell 
signaling downstream of integrins [47]. These events influence diverse cellular 
behaviors, including cell migration, proliferation, survival and apoptosis. In some 
cases, paxillin functions as a structural protein that links other proteins and 
facilitates formation of focal adhesions [26]. However, in other instances, kinases 
may phosphorylate paxillin directly and alter its binding affinity [24]. Paxillin 
localizes to focal adhesions and has been shown to interact directly with the α5 
and α9 subunit of β1 – integrin [48,49,50] and provide a platform for tyrosine 
kinases including FAK and Src that can become activated in response to 
adhesion or growth factor stimulation [26,51,52,53]. Paxillin phosphorylation may 
also regulate the recruitment of downstream molecules such as Crk that can 
further lead to activation of p130Cas [29,47]. In addition, negative regulators of 
these pathways, including Csk and PTP-PEST bind directly to paxillin.   
Previous studies from our laboratory have shown that paxillin is required 
for extracellular pressure to increase cancer cell adhesion, since paxillin 
reduction by siRNA blocks the effect and paxillin overexpression seems to 
reproduce it. Increased extracellular pressure also stimulates paxillin 
phosphorylation at tyrosines 31 and 118 [25,54]. However, it has not been clear 
whether paxillin acts simply as an adaptor protein or whether paxillin 
phosphorylation is necessary for the effects of extracellular pressure on cancer 
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cell adhesion. This is important because understanding how paxillin acts may 
ultimately facilitate the design of therapeutic interventions to reduce cancer cell 
adhesion and metastasis.   
We therefore hypothesized that paxillin phosphorylation is important to the 
regulation of cancer cell adhesion, and sought to test this hypothesis using 
paxillin phosphorylation single mutants that are unable to be phosphorylated at 
tyrosine 31, 118 or 181, a Y31Y118 double mutant and a Y31Y118Y181 triple 
mutant. We transfected these constructs into human SW620 colon cancer cells 
and examined their effects on pressure stimulated cancer cell adhesion. We then 
determined the effects of increased pressure and transfection with non-
phosphorylatable paxillin mutants on the potential paxillin associated molecules 
Crk, Cas and Rac1 to further delineate signaling events downstream of paxillin. 
Next, we examined the association of paxillin with α-actinin a molecules that is 
known to be involved in pressure – stimulated cancer cell adhesion [55], by 
reducing α-actinin levels and evaluating paxillin phosphorylation. Finally, we 
explored these signaling events in primary human colon cancer cells to confirm 
that our observations are not limited to a single cell line.    
We have previously reported that increased extracellular pressure 
promotes paxillin phosphorylation in head and neck cancer cells [54]. However, 
we had yet to identify whether this phosphorylation is important to pressure - 
stimulated cancer cell adhesion. The cells transfected with single plasmid 
phosphorylation mutants all displayed increased adhesion in response to 
increased pressure. However, the cells transfected with the triple mutant did not 
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exhibit an increase in adhesion in response to pressure elevation (Figure 6A, 
n=5; p<0.05). 
 Tyrosine 31 and tyrosine 118 on paxillin are phosphorylated by FAK in 
response to various cellular events, including adhesion [52]. Since FAK is 
involved in pressure - stimulated cancer cell adhesion, we next sought to block 
these two tyrosine phosphorylation sites specifically. We transfected cells with a 
myc-tagged plasmid mutant that is unable to be phosphorylated at both tyrosines 
31 and 118 and similarly evaluated basal and pressure stimulated adhesion. 
Transfection with a construct unable to be phosphorylated at these two tyrosine 
phosphorylation sites was sufficient to block pressure stimulated adhesion 
(Figure 6B, n=4; p<0.05).   
In some other systems, paxillin phosphorylation at tyrosine 31 and 
tyrosine 118 creates a docking site for the adaptor protein Crk [27,52,56,57]. We 
therefore sought to determine whether Crk is also involved in pressure stimulated 
adhesion. Crk was reduced in SW620 cells approximately 74% by siRNA 
treatment and the cells were exposed in ambient or increased pressure (Figure 
7A). When Crk was reduced, pressure did not stimulate cell adhesion (Figure 7B, 
n=4; p<0.05).   
 To evaluate the potential association between paxillin and Crk under 
pressure, we performed co-immunoprecipitation studies using SW620 cells 
exposed to ambient or increased pressure. Indeed, pressure increased the 
association of paxillin with Crk by 36 ± 8% compared to ambient pressure 
controls (Figure 7C, n=6; p<0.05). We therefore, next evaluated the association  
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Figure 6.  Effect of paxillin plasmid phosphorylation mutants on pressure-
stimulated colon cancer cell adhesion.  (A)  15mmHg increased extracellular 
pressure (shaded bars) stimulated SW620 cell adhesion to type I collagen in 
cells transfected with an HA-tagged Y31, Y118 and Y181 paxillin plasmid 
phosphorylation mutant, similar to that observed in wild type transfected cells.  
However, cells transfected with a Y31Y118Y181 plasmid phosphorylation mutant 
did not display increased adhesion in response to elevated pressure (n=5; 
p<0.05).  (B)  SW620 cells transfected with a Y31Y118 paxillin plasmid 
phosphorylation mutant did not display increased adhesion to type I collagen in 
response to elevated pressure (shaded bars) relative to ambient pressure 
controls (open bars) (n=4; p<0.05).   
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A.      B. 
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Figure 7. Crk is necessary for pressure stimulated colon cancer cell 
adhesion and Crk interacts with paxillin.  (A) Typical reduction of Crk in 
SW620 cells transfected with Crk-specific siRNA.  GAPDH was used as a 
loading control and Crk protein expression was normalized against non-targeting 
siRNA controls (n=4; p<0.05).  (B)  Cells transfected with a non-targeting siRNA 
control exhibited increased adhesion in response to 15 mmHg elevated pressure 
(shaded bars).  In contrast, cells transfected with Crk-specific siRNA did not 
display increased adhesion in response to pressure (n=4; p<0.05).  (C)  Equal 
protein samples from SW620 cells that were exposed to ambient (open bar) or 
increased pressure (black bar) were immunoprecipitated for paxillin and probed 
for Crk by western blot.  Samples were normalized against ambient controls 
(n=6; p<0.05). Paxillin-Crk association was increased in pressure-treated cells. 
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of Crk with paxillin in SW620 cells transfected with the paxillin single tyrosine 
mutants and the tyrosine double mutant by similar co-immunoprecipitation 
analysis. Paxillin-Crk interaction was increased under pressure by 34 ± 9%, 27 ± 
4% and 32 ± 6% in the Y31, Y118 and Y181 transfected cells, respectively 
(Figure 8A, n=6; p<0.05). However, the association between paxillin and Crk was 
not significantly increased in the cells transfected with the Y31Y118 double 
mutant (Figure 8B, n=5; p<0.05).   
 To further validate these results, we assessed the interaction of paxillin 
and Crk under ambient and increased pressure conditions in primary human 
colon cancer cells isolated from 6 surgically resected specimens. Primary colon 
cancer cells yielded results similar to SW620 cells. Pressure increased the 
interaction of paxillin and Crk in these human cancer cells by 38 ± 4% (Figure 9, 
p<0.05).   
Cas is a highly phosphorylated protein that may associate with Crk upon 
activation of Cas by Src [30,58,59]. We therefore investigated whether Cas is 
necessary for pressure - stimulated adhesion. We used siRNA to reduce Cas by 
approximately 62% in SW620 cells and exposed the cells to ambient or 
increased pressure (Figure 10A, n=3; p<0.05). Pressure - stimulated adhesion 
was abolished in these cells when siRNA was used to reduce Cas (Figure 10B, 
n=3; p<0.05). To determine if SW620 cells can be rescued from siRNA 
treatment, we transfected the cells with Cas specific siRNA in the presence of a 
Cas rescue plasmid or vector control. Cells transfected with Cas specific siRNA 
and Cas rescue plamid displayed increased adhesion in response to pressure,  
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Figure 8.  SW620 cells treated with paxillin point mutants display increased 
co-immunoprecipitation under pressure, double mutant treated cells do 
not.  (A)  Equal protein samples from SW620 cells that were transfected with a 
HA-tagged Y31, Y118 or Y181 paxillin plasmid phosphorylation mutants and 
exposed to ambient or increased pressure were utilized for co-
immunoprecipitation studies.  Crk co-immunoprecipitation with each mutant was 
significantly increased with elevated pressure (black bars) relative to ambient 
pressure controls (white bars) (n=6; p<0.05).  (B)  Co-immunoprecipitation 
studies were performed on equal protein samples from SW620 cells that had 
been transfected with a myc-tagged Y31Y118 paxillin plasmid phosphorylation 
mutant and exposed to ambient or 15 mmHg increased pressure.  Crk co-
immunoprecipitation with myc tagged paxillin was not increased in response to 
elevated pressure (n=5; p<0.05).   
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Figure 9. Pressure increases co-immunoprecipitation between paxillin and 
Crk in surgically resected human colon cancer cells.  Primary human colon 
cancer cells isolated from surgically resected specimens were exposed to 
ambient or 15 mmHg increased pressure.  Protein samples were used for co-
immunoprecipitation studies and analyzed by western blot to evaluate the 
association of paxillin and Crk. Pressure increased paxillin-Crk association in 
primary colon cancer cells from six patients similarly to our observations in 
SW620 cells. (p<0.05). 
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Figure 10.  Cas is necessary for pressure-simulated adhesion.  (A) Typical 
reduction of Cas in SW620 cells transfected with Cas siRNA.  GAPDH was used 
as a loading control and Cas protein expression was normalized against non-
targeting siRNA controls (n=3; p<0.05).  (B)  15mmHg increased pressure (black 
bars) stimulated the adhesion of SW620 colon cancer cells that had been 
transfected with a non-target siRNA control.  However, cells transfected with 
Cas-specific siRNA did not increase adhesion in response to increased pressure 
(n=3; p<0.05). 
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however, cells transfected with Cas siRNA and vector control did not increase 
adhesion in response to pressure (Figure 11, n=5; p<.05).    
 Since Crk and Cas may interact [60], we compared Crk-Cas interaction 
under conditions of ambient and elevated pressure using co-
immunoprecipitation. Elevated pressure increases the association of Crk and 
Cas by 38 ± 7% (Figure 12, n=6, p<0.05). 
 We further evaluated whether Cas-paxillin association also changes in 
response to increased extracellular pressure. Cas did co-precipitate with paxillin 
under ambient pressure conditions, and the association increased 36 ± 5% under 
increased pressure conditions (Figure 13A, n=4; p<0.05).   
 We performed further studies to examine association between Cas and 
paxillin in cells transfected with the paxillin single and double plasmid tyrosine 
mutants. We found an increase of 30±9%, 24±5% and 32±6% between paxillin 
and Cas under increased pressure conditions in the cells transfected with the 
tyrosine 31, 118 and 181 plasmid mutants, respectively (data not shown; n=6; 
p<0.05). In contrast, the cells transfected with the double tyrosine mutant 
displayed no increase in association between paxillin and Cas after exposure to 
increased pressure (Figure 13B, n=5; p<0.05). 
Activated Cas may phosphorylate and activate members of the small 
GTPase family, such as Rac1, that can in turn influence diverse cellular events 
including migration, motility and adhesion [61,62]. We therefore treated SW620 
cells with NSC23766, an inhibitor of the small GTPase Rac1 and reduced Rac1 
activation by approximately 88% (Figure 14A, n=5; p<0.05). Pressure –  
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Figure 11.  Treatment with Cas rescue plasmid recovers the effect of 
increased pressure on adhesion in the presence of Cas siRNA.  Co-
transfection of SW620 cells with Cas specific siRNA with a plasmid rescue 
construct containing a rat Cas construct resulted in an increased adhesion in 
response to pressure similar to non-targeting controls.  Pressure had no effect in 
cells co-transfected with Cas-specific siRNA and the empty vector control (n=5; 
p<0.05).   
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Figure 12.  Cas and Crk co-immunoprecipitation increases under pressure.  
Co-immunoprecipitation studies were performed using equal protein samples 
from SW620 cells that had been exposed to ambient or increased pressure.  The 
samples were immunoprecipitated for Crk, probed for Cas by western blot and 
normalized against total Crk.  Pressure stimulated Crk-Cas association. (n=6; 
p<.05) 
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Figure 13.  Co-immunoprecipitation of Cas and paxillin increases with 
pressure, however, effect is abolished following treatment with paxillin 
Y31Y118 mutant.  (A)  SW620 cells were exposed to ambient or increased 
pressure.  Equal protein samples were subjected to co-immunoprecipitation.  
Paxillin was immunoprecipitated and Cas was probed for by western blot. 
Pressure stimulated paxillin-Cas association. (n=4, p<0.05).  (B)  Y31Y118 
paxillin plasmid phosphorylation mutant was transfected into SW620 cells that 
were then exposed to ambient or increased pressure.  Protein samples were 
immunoprecipitated for myc-tagged paxillin and cas protein levels were 
evaluated by western blot. Pressure did not stimulate paxillin-cas association in 
these cells. (n=5; p<.05).  
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stimulated adhesion was abolished in cells treated with this inhibitor (Figure 14B, 
n=5; p<0.05). Next, we sought to determine if Rac1 was activated in response to 
elevated pressure. We performed a Rac1 pull down assay and found that Rac1 
was activation was increased by 28% in response to pressure (Figure 15A, n=6; 
p<.05).   
We therefore further evaluated the phosphorylation of Rac1 in response to 
increased extracellular pressure in SW620 cells transfected with either siRNA to 
reduce paxillin or a control non-targeted siRNA sequence. In the control cells, 
Rac1 phosphorylation was increased 38 ±4% under elevated pressure conditions 
(Figure 15B, n=7; p<0.05). However, the cells that were treated with siRNA to 
reduce paxillin showed no increase in phosphorylation in Rac1 in response to 
pressure.   
We have previously shown that pressure – stimulated cancer cell 
adhesion requires FAK, Src and α-actinin. Therefore, we sought to evaluate the 
effect of reducing these molecules on paxillin phosphorylation.   
 We treated SW620 cells with siRNA to FAK and examined paxillin 
phosphorylation at Y31. The results indicated that paxillin Y31 phosphorylation is 
increased under elevated pressure conditions in cells transfected with a non-
target siRNA control. In contrast, cells transfected with siFAK showed increased 
basal phosphorylation, but no additional increase in phosphorylation in response 
to elevated pressure (Figure 16, n=4; p<.05).   
 Next, we treated SW620 cells with PP2, a potent and specific inhibitor of 
Src family kinases. We found that cells treated with a DMSO control displayed  
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Figure 14.  Rac1 is necessary for pressure-stimulated cancer cell adhesion.  
(A)  Typical reduction in phosphorylated (active) Rac1 using NSC23766, an 
inhibitor of Rac1 activation.  Phosphorylated Rac1 levels were normalized 
against actin (n=5; p<.05).  (B)  Wild type SW620 cells displayed increased 
adhesion in response to 15 mmHg increased pressure (shaded bars) relative to 
ambient controls.  However, this effect was not seen in cells treated with 
NSC23766 (n=5; p<.05). 
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Figure 15.  Paxillin affects Rac1 phosphorylation.  (A)  A Rac1 pull down 
assay was performed on SW620 cells that were exposed to ambient or increased 
pressure.  Pressure increased the activation of Rac1 by 28% relative to ambient 
controls (n=6; p<.05).  (B)  SW620 cells transfected with a non-targeting siRNA 
display increased phosphorylation of Rac1 in response to elevated pressure 
(black bars) relative to ambient controls (white bars).  Rac1 phosphorylation is 
not increased in response to elevated pressure in SW620 cells transfected with 
paxillin-specific siRNA (n=7; p<.05).   
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Figure 16.  FAK influences paxillin phosphorylation.  Phosphorylation of 
paxillin at tyrosine 31 increased under pressure in SW620 cells transfected with a 
non-targeting control.  This effect was abrogated in cells transfected with FAK 
specific siRNA (n=4; p<0.05).   
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increased paxillin Y31 phosphorylation in response to pressure, however, the 
cells treated with PP2 had no increase in paxillin Y31 phosphorylation in 
response to pressure (Figure 17, n=5; p<.05). This result was consistent with 
similar observations in cells treated with Src specific siRNA that were probed for 
paxillin phosphorylation at Y31 (data not shown).     
 Finally, we sought to determine if silencing α-actinin with siRNA would 
affect paxillin Y31 phosphorylation. SW620 cells treated with a non-targeted 
siRNA control displayed increased paxillin Y31 phosphorylation. However, cells 
treated with siRNA to reduce α-actinin did not display increased phosphorylation 
in response to elevated pressure (Figure 18, n=6; p<.05).   
Because non – targeting siRNA can potentially affect some proteins, we 
used scrambled siRNA sequences for several of the proteins examined to further 
confirm our results. Cells transfected with scrambled siRNA for paxillin, Crk and 
Cas all displayed increased adhesion in response to increased pressure similar 
to non – targeted controls (Figure 19, n=4; p<.05).   
Tumor cell adhesion in response to elevated pressure is a physiologically 
relevant event, as metastasizing tumor cells are exposed to increased pressure 
during passage through the circulatory or lymphatic systems or during and after 
surgical procedures[63,64,65,66]. Elucidation of the intracellular signaling events 
that influence this adhesion may uncover useful targets to inhibit metastasis. 
Although previous preliminary studies had suggested that paxillin might be 
required for extracellular pressure to stimulate cancer cell adhesion [25,54], it 
was unclear whether paxillin was merely required for focal adhesion assembly  
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Figure 17.  Src influences paxillin phosphorylation.  Treatment of SW620 
cells with PP2 blocked increased phosphorylation of paxillin at tyrosine 31 
compared to non-targeting transfected control cells (n=5; p<0.05).   
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Figure 18.  Alpha-actinin influences paxillin phosphorylation.  Paxillin 
phosphorylation in response to pressure was higher in SW620 cells transfected 
with a control non-targeting siRNA but not in cells transfected with alpha-actinin-1 
specific siRNA (n=6; p<0.05).   
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Figure 19.  Scrambled siRNA does not inhibit pressure-stimulated colon 
cancer cell adhesion.  Pressure elevations of 15 mmHg induced increases in 
adhesion in SW620 cells transfected with scrambled siRNA sequences for 
paxillin, Crk and Caswere similar to that in the non-targeting controls (n=5; 
p<0.05).   
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and linkage to the cytoskeleton or whether paxillin actually participated in a 
dynamic signal pathway stimulated by increased extracellular pressure. Our 
current data indicate that paxillin phosphorylation at tyrosines 31 and 118 
together is necessary for pressure-induced adhesion. Furthermore, 
phosphorylation at these two sites creates a binding site for the adaptor protein 
Crk, leading to the recruitment of p130Cas and ultimately to the phosphorylation 
of Rac1. Each of these steps seems required for extracellular pressure to 
activate cancer cell adhesion.   
Paxillin influences tumor biology in several ways. It participates in focal 
adhesion assembly and links the focal adhesion complex to integrins and to the 
cytoskeleton [26,67]. Paxillin expression is increased in metastatic head and 
neck cancer and human osteosarcomas as well as aggressive breast cancer cell 
lines [68,69,70].   
In some instances, paxillin acts simply as a scaffolding protein that 
functions to provide docking sites for a variety of structural and signaling 
proteins.  For example, in lymphoid cells, paxillin has been shown to bind directly 
to the α4 integrin subunit [24]. Paxillin also provides a docking site for the protein 
tyrosine kinases FAK and Src, which can in turn participate in diverse signaling 
pathways [26]. A recent study by Geiger et al indicated that non-phosphorylated 
paxillin is essential for the formation of fibrillar adhesions, and leads to enhanced 
fibronectin fibrillogenesis in Porcine aortic endothelial cells [71]. In other 
situations, paxillin phosphorylation is necessary for downstream signaling and 
cellular functions. This necessity for phosphorylation is evident in a current study 
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by Vallés et al that showed blocking paxillin tyrosine phosphorylation at sites 31 
and 118 in NBT-II rat bladder carcinoma cells decreased motility on collagen by 
approximately 50% [27]. In the current study we sought to determine the 
relevance of paxillin tyrosine phosphorylation to pressure-stimulated colon 
cancer cell adhesion. 
Pressure appears to stimulate paxillin tyrosine phosphorylation at both 
tyrosine 31 and tyrosine 118. Using plasmid phosphorylation mutants, we found 
that tyrosine phosphorylation at sites 31 and 118 individually did not affect 
pressure stimulated cancer cell adhesion. However, when both sites were 
blocked simultaneously, the pressure effect was abolished. In contrast, point 
mutation of tyrosine 181 seemed irrelevant. These results are consistent with 
observations that paxillin tyrosine 31 and 118 phosphorylation is necessary for 
adhesion, migration and cell spreading in other systems  [47,72,73]. Recent data 
has also implicated serine 273, as well as serine 188 and 190 phosphorylation as 
influencing cell adhesion [74,75]. Although this result was obtained in epithelial 
cells after adhesion had occurred, our present studies of paxillin tyrosine 
phosphorylation certainly do not preclude the possibility that this serine 
phosphorylation event may also occur in response to extracellular pressure.     
Crk is a multifunctional adaptor protein that has been reported to bind to 
many different intracellular proteins, depending upon the cell type and stimulus 
studied. For instance, Crk can interact with phosphatidylinositol kinase (PI3 
kinase), leading to the activation of the Akt signaling pathway [76], which also 
influences colon cancer cell adhesion in response to extracellular pressure [77]. 
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Others have reported that Crk binds to the adaptor proteins DOCK180 and C3G 
in a variety of cell types, and that these downstream proteins then can then 
regulate cell migration or the mitogen activated protein kinase pathway, 
respectively [78,79]. The results presented here indicate that paxillin 
phosphorylation within colon cancer cell lines or primary human colon cancer 
cells in response to extracellular pressure facilitates paxillin-Crk binding, which is 
also required for the ultimate stimulation of adhesion. The potential role of Crk in 
modulating pressure stimulated cell adhesion has not previously been evaluated. 
Our studies were designed to delineate the intracellular signaling in suspended 
cells prior to adhesion that would then govern their subsequent adhesion; while 
most other studies have evaluated Crk signaling in cells after adhesion had 
occurred. Whether other proteins that interact with Crk may also participate in 
pressure – induced signaling in cells prior to adhesion awaits further study.   
p130Cas is also an adaptor that promotes protein – protein interactions 
[30]. Cas interaction with other proteins modulates diverse cellular events 
[58,60,80,81]. Cas modulates cell motility, and integrin – mediated cell adhesion 
triggers Cas tyrosine phosphorylation that has been correlated with actin 
cytoskeleton reorganization and focal adhesion formation [58]. However, the 
ability of Cas to influence the binding affinity of suspended cells is less clear. Our 
observations of Cas paralleled our studies with Crk. Paxillin phosphorylation in 
response to pressure facilitates paxillin-Cas binding just as it does paxillin-Crk 
binding. Cas is required for the stimulation of adhesion, however, the pressure 
effect can be rescued from Cas siRNA treatment when a wild type Cas plasmid is 
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transfected in conjunction with Cas specific siRNA. Although Cas has been 
reported to associate with a wide variety of proteins, the present results suggest 
a model in which paxillin, Cas, and Crk form a trimeric complex in response to 
paxillin phosphorylation stimulated by pressure. This would be consistent with 
similar observations in collagen stimulated NBT-II cells [82] as well as in 
migrating FG-M carcinoma cells on vitronectin [60], although others have found 
that Cas binds to the Tec/Btk family member Bmx in Cos-7 cells in response to 
adhesion [83]. The differences between our observations and some of these 
other reports may reflect differences in the cell types and stimuli studied. 
Rac1 is a known binding partner of Cas, although Rac1 also binds to and 
is activated by RhoG and aldosterone in other settings [84,85]. We therefore 
hypothesized that the paxillin-Crk-Cas interaction might relevantly phosphorylate 
and activate Rac1. Indeed, Rac1 is phosphorylated and activated in response to 
extracellular pressure. Furthermore, reduction of paxillin by targeted siRNA 
prevented increased Rac1 phosphorylation in response to elevated pressure. 
Whether paxillin interacts directly with Rac1 or simply facilitates Cas 
conformational changes that permit Cas phosphorylation of Rac1 awaits further 
study. 
Several investigators have reported that Rac1 is important in actin 
polymerization, lamellipodial extension, and cell migration in various cell types, 
but that Rac1 is not critical for adhesion itself [86,87,88,89]. Indeed, Rac1 
inhibition by NSC23766 produced little effect on basal cell adhesion in our 
studies. However, Rac1 inhibition completely prevented the stimulation of 
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adhesion by extracellular pressure. Force-activated adhesion may be regulated 
by a very different pathway than basal adhesion. We have previously reported 
that reduction of some other signals in this pathway, such as α-actinin; also have 
little effect on basal adhesion while nonetheless preventing the stimulation of 
adhesion by pressure [55]. 
If paxillin phosphorylation is a critical event in pressure-stimulated 
adhesion, what cellular events might trigger this phosphorylation in response to 
extracellular pressure increases? A recent report by Chien et al suggests that 
modifications of microtubule dynamics can increase paxillin phosphorylation, 
although a mechanism for this effect was not explored [90]. FAK and Src are 
focal adhesion proteins that are involved in intracellular signaling that regulates 
proliferation, apoptosis, migration, and adhesion in both normal and tumor cells 
[51]. FAK is phosphorylated at tyrosine 397 in response to various stimuli, 
including adhesion itself and extracellular pressure prior to adhesion [41,91]. This 
phosphorylation creates a binding site for Src where Src becomes activated and 
further phosphorylates FAK. The FAK-Src complex is thought to control focal 
adhesion turnover and target paxillin and Cas for phosphorylation [92]. 
Individually, FAK and Src have also been shown to be activated by various 
stimuli, including PDGF, insulin and growth hormone, where they can directly 
activate the MAP kinase pathway and promote cell migration [93,94,95]. Our 
previous studies have shown that pressure – stimulated cancer cell adhesion is 
dependent upon FAK and Src phosphorylation [41]. We therefore sought to 
determine if either FAK or Src are required to for the stimulation of paxillin 
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phosphorylation by elevated pressure. In our model, FAK reduction by targeted 
siRNA stimulated basal paxillin phosphorylation at ambient pressure but 
prevented further phosphorylation in response to pressure. The increase in 
ambient pressure phosphorylation is consistent with reports that FAK null 
fibroblasts display increased paxillin phosphorylation [96]. Although this increase 
in basal paxillin phosphorylation in FAK null cells has not been explained, it may 
reflect microtubular destabilization by FAK reduction, as has been reported in 
neuronal cells as well as in mouse fibroblasts [97,98]. However, the blockade of 
stimulation by pressure of paxillin phosphorylation in FAK-reduced cells suggests 
a role for FAK in this effect. Src inhibition also prevented the stimulation of 
paxillin phosphorylation by pressure, although without a notable effect on basal 
ambient pressure phosphorylation, again suggesting that paxillin is probably 
downstream of FAK and Src in the signal pathway by which suspended cancer 
cells respond to extracellular pressure. Previous studies have suggested that 
paxillin phosphorylation does increase in response to elevated pressure in cells 
treated with FAK-specific siRNA or PP2 [25]. However, we obtained a greater 
reduction in FAK levels (~70%) and treated with PP2 for a longer amount of time 
(4 hours) which could account for this difference.   
α-Actinin is an actin crosslinking protein that interacts with multiple focal 
adhesion proteins and is able to bind to the cytoplasmic tail of β1 integrin. α-
Actinin is also a FAK substrate and enhances the interaction between FAK and 
Src. Additionally, reduction of α-Actinin by siRNA blocks pressure – stimulated 
cancer cell adhesion [55]. In the current study, when α-Actinin was reduced by 
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siRNA treatment, paxillin phosphorylation at tyrosine 31 was inhibited. This would 
be consistent with a model in which FAK and Src interaction with α-Actinin is 
necessary for paxillin phosphorylation in response to pressure.   
Finally, to further validate our results that used non – targeting control 
siRNA, we found that treatment with scrambled siRNA sequences for paxillin, Crk 
and Cas did not influence pressure – stimulated adhesion.    
In summary, pressure stimulated colon cancer cell adhesion depends 
upon paxillin, and more specifically, upon paxillin phosphorylation at tyrosines 31 
and 118. The phosphorylation of paxillin is dependent upon α-actinin and leads to 
association with Crk and Cas and downstream activation of Rac1. This pressure-
activated pathway seems clinically relevant, as increased extracellular pressure 
stimulates colon cancer cell adhesion to endothelial cells in vitro and surgical 
wounds in vivo, and has been shown to influence tumor-free survival in a murine 
transplantable tumor model [22,41,99]. Although complete delineation of the 
pressure-sensitive signal pathway responsible for this effect awaits further study, 
paxillin and its binding partners seem critical to the adhesion process and may 
offer innovative therapeutic targets.      
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CHAPTER 5 
NF-kB Dependent Pressure-Induced Proliferation 
Extracellular pressure increases of 15mmHg above ambient for 1-30 
minutes stimulate β1-integrin binding affinity in suspended cancer cells before 
adhesion through FAK, Src and Akt activation, and β1-integrin phosphorylation 
[100]. Prolonged pressures of similar magnitude stimulate proliferation in 
mesangial cells during glomerular hypertension, cardiac myocytes after 
abdominal aortic constriction, and in endothelial cells [101,102,103]. Preliminary 
studies from our laboratory demonstrated that 15mmHg increased pressure 
stimulates SW620 and HCT-116 colon cancer cell proliferation [31]. In contrast to 
the stimulation of cancer cell adhesion by extracellular pressure [100] or the 
stimulation of proliferation in Caco-2 cells by cyclic strain [104], the mitogenic 
effect of pressure appears independent of Src, but its underlying mechanism is 
largely unclear.   
 Physical forces may activate mitogenic signals varying with the cell and 
stimulus studied, including MAPK, Rho GTPases, and integrin activation. Two 
prominent candidates to mediate the mitogenic effects of pressure are Rac1 and 
NF-kB. Rac1 can be activated by forces such as deformation and pressure, and 
can modulate proliferation, adhesion, and migration [105,106]. NF-kB is a rapidly 
acting transcription factor that modulates gene transcription in cell-cycle 
regulation, apoptosis, and proliferation. NF-kB family members share a Rel 
homology domain in their N-terminus. However, RelA, RelB and c-Rel are the 
only members with transactivation domains. NF-kB family members form 
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homodimers or heterodimers to participate in transactivation. RelA, the p65 
subunit, regulates transcription directly, as it has a nuclear translocation 
sequence in addition to a direct DNA binding site. Traditional NF-kB signaling 
involves heterodimerization between RelA and p50. NF-kB can promote or inhibit 
apoptosis depending upon the stimulus [35]. For example, NF-kB promotes 
apoptosis in colon cancer cells treated with aspirin [107]. In contrast, murine B 
cell proliferation is suppressed when NF-kB is blocked and constitutive NF-kB 
activation in gastric cancer cells promotes proliferation [36,108].   
 We hypothesized that pressure stimulates cancer cell proliferation via NF-
kB activation. We measured intratumoral pressure directly in patients to confirm 
that pressure was increased within tumors, although we were not able to localize 
tumor center or periphery sufficiently to document the intratumoral pressure 
gradient observed by others [109]. We examined the proliferative response to 
increased extracellular pressure of 3 colon cancer cell lines, a breast cancer line, 
and a prostate cancer line. These studies were repeated after treatment with 3 
NF-kB inhibitors or NF-kB-specific small interfering RNA (siRNA). We also 
evaluated pressure effects on NF-kB nuclear translocation, NF-kB transcription 
factor activity, and NF-kB-driven events that can stimulate proliferation, including 
IKK and IkB phosphorylation and cyclin D1 expression. We further examined NF-
kB activity in pressure-treated cells treated with inhibitors of FAK, Akt and Protein 
Kinase C (PKC). Finally, we compared IkB phosphorylation, NF-kB, and cyclin D 
expression, and proliferation in the relatively lower pressure peripheries and the 
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relatively higher pressure centers of 28 large primary tumors to validate our in 
vitro findings.   
 We confirmed previous reports of increased extracellular pressure within 
human tumors [110] by measuring interstitial pressure just outside 13 human 
intraabdominal malignant tumors and then within them during image-guided 
biopsy. Pressures within the tumors were greater than pressures in adjacent 
tissue (Figure 20, n=13,p<0.05). 
 SW620, Caco-2 and CT-26 colon cancer, MCF-7 breast. and PC3 
prostate cancer cells were exposed to 0-80mmHg increased extracellular 
pressure for 24 hours and proliferative activity was assessed by MTT assay. 
Each cell line displayed increased MTT fluorescent intensity across the range of 
increased pressures, with greatest responses at 40-60mmHg increased pressure 
(Figure 21, n=13;p<0.05). Parallel manual cell counting confirmed increased cell 
numbers after exposure to 40 mmHg increased pressure vs. ambient 
(n=4;p<0.05, not shown). The Rac1 inhibitor NSC23766 did not prevent 
increased MTT fluorescent intensity in pressure-treated cells (Figure 22, 
n=4;p<0.05), but the NF-kB inhibitor SN50, an NF-kB nuclear decoy, a novel 
imidazoline inhibitor, TCH-021, or NF-kB specific siRNA abolished the effect. 
Pressure remained mitogenic in cells treated with an inactive SN50 analog, an 
inactive NF-kB nuclear decoy, or a non-targeting control siRNA sequence (Figure 
22, n=6;p<0.05). To contrast pressure stimulation of adhesion and proliferation, 
SW620 cells were treated with the NF-kB inhibitor SN50 and exposed to ambient 
or 40mmHg increased pressure during a 30 minute adhesion assay. Adhesion  
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Figure 20.  Extracellular pressure in human tumors.  Tissue pressure was 
measured just outside and within 13 human intraabdominal malignant tumors.  
Pressure was increased inside the tumors relative to outside.    
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Figure 21.  Extracellular pressure stimulates the proliferation of various 
cancer cell lines.  40mmHg increased pressure (shaded bars) stimulated 
proliferation in SW620, CT26 and Caco-2 colon cancer cells, MCF-7 breast 
cancer cells and PC3 prostate cancer cells.   
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Figure 22.  Increased proliferation in response to extracellular pressure is 
abolished in the presence of NF-kB inhibitors.  Proliferation in response to 
40mmHg increased pressure (shaded bars) is blocked in SW620 cells treated 
with SN50, a NF-kB nuclear decoy, TCH-021 and NF-kB specific siRNA, but not 
after treatment with the inactive SN50 analog, the inactive nuclear decoy or the 
Rac1 inhibitor NSC23766. 
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increased similarly in both control and NF-kB-inhibited cells (Figure 23, 
n=4;p<0.05). To further characterize the effect of increased pressure on cell 
cycle regulation, SW620 cells were treated with inhibitors, exposed to 24 hours of 
ambient or 40mmHg increased pressure, and cell cycle analysis was performed 
by flow cytometry. S-phase fractions increased 22±6% in untreated cells exposed 
to increased pressure (Figure 24, n=3;p<0.01). However, pressure did not 
increase S-phase fractions in inhibitor-treated cells (Figure 24, n=4;p<0.05). 
Finally, TUNEL staining demonstrated that pressure did not alter SW620 cell 
apoptosis (Figure 25, n=3;p<0.05). 
 To determine whether pressure activated NF-kB, we treated SW620 cells 
with NF-kB lentiviral reporter particles expressing firefly luciferase and incubated 
them under ambient or 40mmHg increased pressure for 24 hours. Pressure 
increased NF-kB activation 94±7% (Figure 26A, n=12;p<0.05). However, the NF-
kB inhibitors SN50 and TCH 021, the NF-kB nuclear decoy, and siRNA to NF-kB 
each prevented pressure-associated NF-kB activation (Figure 26A, n=6;p<0.05). 
NF-kB activation is typically accompanied by nuclear translocation. We therefore 
evaluated NF-kB p50 and p65 levels in nuclear fractions derived from SW620 
cells exposed to ambient or 40mmHg increased pressure for 24 hours. p50 and 
p65 nuclear translocation increased 58±6% and 67±8% respectively in pressure-
treated cells compared to ambient pressure (Figure 26B, n=6;p<0.05).   
NF-kB is sequestered within the cytosol by binding its inhibitor IkB. When 
IkB is phosphorylated by the kinase IKK, released NF-kB translocates to the 
nucleus [35,111]. IKK phosphorylation was increased 27±4% in pressure-treated  
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Figure 23.  NF-kB inhibition has not effect on pressure stimulated cancer 
cell adhesion.  40mmHg increased pressure (shaded bars) increased SW620 
cell adhesion on collagen in the presence of SN50 control and SN50 inhibitory 
peptide. 
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Figure 24.  SW620 colon cancer cells increase S-phase fractions in 
response to elevated pressure.  S-phase fractions increased in SW620 cells 
exposed to 40mmHg pressure (shaded bars) after no prior treatment or SN50 
inactive peptide treatment.  Cells treated with the NF-kB inhibitors SN50, a NF-
kB nuclear decoy, or TCH-021 showed no increase.   
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Figure 25.  No changes in apoptosis are observed in pressure treated cells.  
TUNEL staining in SW620 cells after treatment with SN50, a NF-kB nuclear 
decoy or TCH-021 showed no changes in apoptosis with pressure.    
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Figure 26.  Effect of increased pressure on NF-kB activity and nuclear 
localization.  (A) Pressure (shaded bars) increased SW620 NF-kB activity.  This 
increase was abolished by SN50, a NF-kB nuclear decoy, or TCH-021.  (B) NF-
kB p65 and p50 increased in nuclear fractions from SW620 cells exposed to 
increased pressure, using histone H1 as a loading control.   
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cells relative to ambient control cells (n=8;p<0.05, not shown). We also observed 
a 61±8% increase in IkB phosphorylation in pressure-treated cells compared with 
cells at ambient pressure (Figure 27A, n=8;p<0.05). Elevated pressure also 
decreased NF-kB-IkB association 31±4% (Figure 27B, n=5;p<0.05). Cyclin D1 is 
influenced by NF-kB and regulates the G1-S phase transition [34]. We therefore 
compared cyclin D1 expression in SW620 cells at ambient or increased pressure 
for 24 hours. Pressure-treated cells expressed 26±5% more cyclin D1 than 
ambient pressure controls (Figure 28, n=6;p<0.05). This increase was abolished 
in cells pre-treated with the NF-kB inhibitors SN50 or TCH 021, with a nuclear 
decoy, or with siRNA to NF-kB (Figure 28, n=5;p<0.05). NF-kB family members 
form homo- or heterodimers prior to nuclear localization and transcription factor 
activation. Traditional NF-kB signaling involves the p50/p65 dimer. NF-kB p65 
and p50 transcription factor activity increased 48±6% and 50±4% respectively in 
response to pressure (Figure 29, n=6;p<0.05).   
 NF-kB activation and subsequent signaling in response to some stimuli 
may be influenced by PKC. Go6976, which inhibits both PKC-α and PKC-β, and 
a pure PKC-β inhibitor abolished the effect of pressure on proliferation. However, 
elevated pressure increased proliferation in cells treated with a PKC-ε 
translocation inhibitor, similarly to untreated controls (Figure 30A, n=9;p<0.05). 
Inhibiting PKC-α/β in combination, or inhibiting PKC-β alone also abolished NF-
kB activation in response to pressure (Figure 30B, n=9;p<0.05). FAK and Akt 
mediate the effects of extracellular pressure on integrin-mediated adhesion as 
well as the stimulation of proliferation by another physical force, cyclic  
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Figure 27.  Effect of pressure on NF-kB signaling.  (A)  Pressure (shaded 
bars) increased SW620 IkB (serine273) phosphorylation vs. ambient pressure 
(open bars), using actin as a loading control.  (B)  Co-immunoprecipitation 
revealed reduced association between NF-kB(p65)/IkB under increased pressure 
(shaded bars).  Total NF-kB was a loading control.   
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Figure 28. Cyclin D1 expression increases in response to pressure.  SW620 
cyclin D1 expression increased after exposure to increased pressure (shaded 
bars).  This increase was abolished by SN50, a NF-kB nuclear decoy or TCH-
021.  Actin was a loading control.   
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Figure 29. Extracellular pressure increases NF-kB p65 and p50 
transcription factor activity.  Pressure (shaded bars) increased NF-kB p50 and 
p65 transcription factor activity in SW620 nuclear fractions relative to ambient 
controls.   
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Figure 30.  PKC α/β inhibition abolishes pressure-stimulated proliferation 
and NF-kB activation.  (A) Inhibiting PKC-β or PKC α/β abolished pressure-
stimulated proliferation. PKC-ε inhibition did not.  (B)  PKC-β and PKC α/β 
inhibition blocked the effect of increased pressure on NF-kB activation. PKC-ε did 
not.   
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deformation [100]. However, inhibition of FAK or Akt did not prevent the 
mitogenic effects of pressure on NF-kB activation, unlike global PKC inhibition 
using calphostin C (Figure 31, n=9;p<0.05). The IKK complex is required for IkB 
phosphorylation and subsequent NF-kB activation. To evaluate the effect of IKK 
subunits on pressure-stimulated NF-kB activation, we treated SW620 cells with 
inhibitors to IKK-2 or IKK-3, or an IKK inhibitor that blocks IkB phosphorylation. 
Individually, these inhibitors did not prevent pressure activation of NF-kB (Figure 
32A, n=12;p<0.05). However, when IKK-2 and IKK-3, or IKK-2 and the IkB 
phosphorylation were blocked together, pressure activation of NF-kB was 
abolished. Pressure-induced NF-kB activation was also reduced when all three 
inhibitors were combined (Figure 32B, n=12;p<0.05).     
 Since extracellular interstitial pressures are higher in the center of many 
solid human tumors than at their peripheries [109,110], we compared mitotic 
rates at the periphery and center of 28 human colon, lung, and head and neck 
tumors, averaging 8±1.2cm diameter. A reviewer blinded to the hypothesis 
reported a 154±14% increase in mitotic figures/high power field in the central 
regions of the tumors relative to their peripheries (Figure 33, n=15;p<0.05). 
Parallel studies demonstrated very high immunoreactivity for active NF-kB, 
phosphoIkB, and cyclin D1 in the centers of these tumors which decreased 
towards their peripheries. Little or no staining was observed in adjacent non-
malignant tissues from each specimen (Figures 34-36, n=27;p<0.05). 
Assessment of immunoreactivity on a scale from 0 (negative staining) to 4 (high 
staining), specimens immunostained for NF-kB were scored in 95 zones from  
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Figure 31.  Effect of FAK, Akt and PKC inhibition on pressure-stimulated 
proliferation.  Inhibiting FAK and Akt did not affect pressure-induced NF-kB 
activation, but PKC blockade abolished the effect.   
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Figure 32.  IKK inhibition affects pressure stimulated NF-kB activation in 
combination.  (A) Inhibitors of IKK-2, IKK-3 and IKK phosphorylation of IkB did 
not reduce pressure-stimulated NF-kB activation when used individually.  (B)  
Combination of IKK-2 and IKK inhibitor of IkB phosphorylation abolished 
pressure-stimulated NF-kB activation, as did IKK-2 and IKK-3, or all three 
inhibitors together.   
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Figure 33.  NF-kB immunostaining increases in the center of human 
tumors.  Immunohistochemical staining of colorectal carcinomas, representative 
of staining observed in colorectal, head and neck and lung tumors.  To obtain a 
full view of the sample, a panel of photographs were taken and placed together.  
Dashed lines represent zones of overlap within the image.  Panel images were 
taken at 4X magnification and images within each zone at 20X.  Staining 
represents active NF-kB. 
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Figure 34.  Phospho-IkB staining in the center of human tumors.  
Immunohistochemical staining of colorectal carcinomas, representative of 
staining observed in colorectal, head and neck and lung tumors.  To obtain a full 
view of the sample, a panel of photographs were taken and placed together.  
Dashed lines represent zones of overlap within the image.  Panel images were 
taken at 4X magnification and images within each zone at 20X.  Staining 
represents phospho-IkB.   
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Figure 35.  Cyclin D1 staining in the center of human tumors.  
Immunohistochemical staining of colorectal carcinomas, representative of 
staining observed in colorectal, head and neck and lung tumors.  To obtain a full 
view of the sample, a panel of photographs were taken and placed together.  
Dashed lines represent zones of overlap within the image.  Panel images were 
taken at 4X magnification and images within each zone at 20X.  Staining 
represents cyclin D1.   
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Figure 36.  Mitotic index increases in the center of human tumors.  Mitotic 
index increases in tumor centers vs. peripheries.  Non-malignant tissue showed 
minimal staining and few mitotic figures.   
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adjacent histologically normal margins from 19 different tumor samples and 
averaged a score of 0.8. Blinded evaluation of areas at the periphery of the 
tumors in these same slides yielded a mean score of 2.2, while central tumor 
zones received a mean score of 3.6. Similar gradients occurred for phospho-IkB 
and cyclin D1 immunoreactivity (Table 3). Differences between the normal tissue, 
the peripheral zone, and the central tumor zone were each statistically significant 
(p<0.01). Mitotic figures were separately counted in 20 fields of highly NF-kB-
immunoreactive areas within the tumors compared to less NF-kB-
immunoreactive areas, confirming a 124±8% increase in mitotic figures within 
these more immunoreactive zones (p<0.05, not shown).   
 Tumor cells are exposed to increased extracellular pressure during 
passage through the circulatory and lymphatic systems [65,112]. Intraabdominal 
pressures can reach 15-30mmHg post-operatively as fluid is sequestered within 
the extracellular space of the viscera, causing swelling against the abdominal 
wall [113]. Although we and others have suggested that increased extracellular 
pressure can stimulate cancer cell proliferation, the mechanism has been 
unknown [31,114]. Cells respond to numerous mitogenic intracellular signals, 
including Src, FAK, MAPK, and Rac1. However, blocking Src, FAK or the MAPK 
does not prevent the mitogenic effects of pressure [31,115], and blocking Rac1 
did not inhibit the mitogenic effects of pressure here. In contrast, NF-kB is a 
transcription factor that in some instances can be pro-apoptotic and in others 
mitogenic, depending on the stimulus and setting [34]. Our data suggests that 
increased extracellular pressure stimulates cancer cell proliferation through  
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Table 3.  Immunohistochemical Scores 
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PKCα/β-dependent IKK and IkB phosphorylation, NF-kB activation and nuclear 
translocation, and increased cyclin D1 expression.   
Mitogenic signaling in response to forces such as pressure may influence 
the proliferation of many cell types [17,31,116]. Less than 5mmHg of pressure 
stimulates endothelial proliferation, while 70mmHg pressure increases 
osteosarcoma proliferation and 160mmHg stimulates aortic myocyte proliferation 
[65,103,117]. In contrast, neuronal cell lines display apoptosis after 2 hours of 
100mmHg increased pressure, and 40-80mmHg pressures increase human 
mesangial cell proliferation, while pressures of 100-180mmHg stimulate 
apoptosis in the same cells [118,119]. Although these results support an effect of 
pressure on proliferation in some cell types, how this occurs has not been 
elucidated. Several theories have been advanced. Some have hypothesized that 
pressure-exposed cells secrete a factor into the medium that influences 
proliferation, while others suggest that the disruption of the attachment between 
integrins and the cytoskeleton is responsible [114]. Additionally, non-malignant 
cells seem to respond to a lesser stimulus than their malignant counterparts, and 
malignant cells seem to have a threshold by which a proliferative response to 
pressure may turn apoptotic [103,117]. This study focused on pressures within 
the range typically experienced by tumor cells in vivo, and found that such 
pathophysiologically relevant pressure increases stimulate the MTT-based 
reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide to 
formazan, and increase S-phase fraction and cell numbers in colon, breast and 
prostate cancer cells. Apoptosis did not change. Taken together, these results 
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strongly suggest that pressure increases cell number by stimulating proliferation, 
rather than inhibiting apoptosis.  
Previous studies suggest that pressure stimulates the adhesion of 
suspended cancer cells to matrix proteins, endothelial cell monolayers and 
surgical wounds in a manner that depends upon an intact cytoskeleton, as well 
as PI-3-kinase and Src signaling [100]. However, the pathway by which pressure 
stimulates proliferation seems different from the signaling mediating pressure-
stimulated adhesion, because in the previous preliminary study the mitogenic 
effects of pressure were not prevented by inhibiting Src or PI-3-kinase, or the 
actin stablilization agent phalloidin, although these each prevent pressure 
stimulation of adhesion in suspended cells [31,100]. Our current study further 
confirms that pressure stimulates adhesion and proliferation by different 
pathways, and that pressure acts differently from repetitive deformation. Rac1 is 
required for pressure-stimulated adhesion [105] and the mitogenic effects of 
repetitive deformation in human Caco-2 colon cancer cells and non-malignant 
IEC-6 intestinal epithelial cells [120] but does not seem to contribute to the 
mitogenic effects of pressure. The differences between those previous 
observations and the present data likely reflect differences in the signaling of 
cancer cells not yet adherent to matrix proteins (thus lacking a background of 
integrin-driven intracellular signaling) and in the responses to constant pressure 
compared with cyclic deformation.  
NF-kB signaling is complex, and can promote proliferation through 
increased expression of cell cycle regulators, or cell death through interactions 
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with anti-apoptotic factors such as FLIP and TRAF1/2 [34]. NF-kB is activated in 
response to deformation. Mechanical stretch activation of NF-kB in muscle cells 
increases TNF-alpha and IL-1B expression, while osteoblast-like MF-63 cells 
display NF-kB activation in response to low amplitude cyclic strain, but not low 
amplitude compressive strain. Interestingly, this effect was reversed at high 
amplitude cyclic and compressive strain [121,122]. High pressures can also 
activate NF-kB [123]. In our current study, pressure stimulated NF-kB nuclear 
translocation of the p50 and p65 subunits, as well as NF-kB activation. This 
occurred through phosphorylation of the IKK complex and subsequent IkB 
phosphorylation. NF-kB activation increased cyclin D1 expression and 
proliferation.   
FAK and Akt are necessary for pressure-induced adhesion and the 
mitogenic effects of repetitive deformation [100], and also often mediate NF-kB 
activation [124,125]. However, inhibition of FAK or Akt did not prevent pressure 
activation of NF-kB here. Conversely, some PKC isoforms can also influence NF-
kB activation and proliferation. Controversy exists over whether PKC-α or PKC-ε 
mediates NF-kB activation in T cells [126,127]. In colon cancer cells, PKC-τ has 
been reported to regulate NF-kB [128]. In our study, inhibiting PKC-β or PKC α/β, 
but not PKC-ε, prevented pressure activation of NF-kB. Intestinal epithelial 
proliferation in response to strain depends on PKC-α which, like PKC-β, requires 
calcium for activation [129]. In contrast, PKC-ε is representative of the calcium-
independent family. The role of calcium in pressure-mediated proliferation awaits 
further study.   
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The IKK complex is responsible for IkB phosphorylation and subsequent 
NF-kB activation. TNF-α is required to activate this complex. The IKK-2 inhibitor 
we used is reported to function by inhibiting TNF-α production, while the IKK-3 
inhibitor is an ATP-competitive inhibitor. The global IKK inhibitor is thought to 
block IkB phosphorylation directly. The roles of the IKK isoforms are diverse and 
vary with cell type. IKK-2 is necessary for myeloma cell proliferation, but IKK-2 
deletion increases myocyte proliferation [130,131]. Although the individual 
inhibitors of IKK-2, IKK-3 and IKK phosphorylation of IkB did not prevent 
pressure activation of NF-kB, using these inhibitors in combination blocked this 
effect, indicating pathway redundancy but confirming IKK relevance.     
Aberrant or constitutive NF-kB activation characterizes many human 
malignancies and indicates poor prognosis in colorectal and esophageal cancers 
[34,36,37]. We observed intense NF-kB, IkB, and cyclin D1 immunoreactivity in 
the high pressure center of the tumors which was reduced towards the lower 
pressure periphery and virtually absent in the adjacent normal tissue. These 
were all solid tumors without significant necrosis, which could have affected 
intratumoral pressures. NF-kB immunoreactivity of this magnitude correlates with 
poor prognosis [38]. Correlation does not prove causation, but our observations 
in human tumors suggest at least a potential causal link between pressure-
mediated NF-kB activation and increased proliferation in tumors that is further 
supported by our in vitro mechanistic studies.   
 In conclusion, pathophysiologically relevant increases in pressure 
stimulate colon, breast and prostate cancer cell proliferation by a mechanism 
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involving activation of PKC and the IKK complex, and NF-kB p50 and p65 
nuclear localization and activation, and increased cyclin D1 expression. This 
effect may explain, in part, the increased NF-kB, IkB and cyclin D1 
immunoreactivity and increased proliferation that we observed within the higher 
pressure centers of human tumors. Tumor growth involves numerous signaling 
cascades. These results suggest that the increases in extracellular pressure 
generated by tumor growth and stiff tumor matrix may themselves stimulate 
proliferation within the tumor, generating a positive feedback loop. This pathway 
may represent a target of opportunity to slow the growth of unresectable tumors 
in patients and tumors not candidates for conventional cytotoxics.  
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 6 
Pressure-Induced Metastatic Signaling In Vivo 
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 We hypothesized that cancer cells are activated by the increased 
pressures and shear forces of the circulation, leading to increased adhesion and 
metastasis, and that blocking this activation can reduce metastasis.     
It has been estimated that nearly 1 X 106 tumor cells per gram of tumor 
tissue are shed into the bloodstream each day [132]. In addition, viable tumor 
cells can be recovered from the peripheral blood of more than 40% of patients 
immediately following “curative” colon tumor resection surgery, indicating a poor 
prognosis [133,134]. Such circulating cancer cells encounter many host 
responses, including immune system interference, but some surmount these 
hurdles and progress to metastatic disease.   
 0.8-1.0% of patients may experience wound implantation following tumor 
resection surgery, while laboratory studies suggest that CT-26 murine colon 
cancer cells exposed to 30 minutes of 15mmHg increased pressure adhere to 
surgical wounds significantly greater than those cells left in ambient pressure 
conditions [135,136]. However, although local surgical site recurrence can be an 
important adverse event, most metastasis occurs via distant spread through the 
lymphatic, venous, and arterial circulation [137]. Such metastatic progression 
depends upon tumor cell adhesion at a distant site, but the factors that influence 
cancer cell adhesion are incompletely understood. Some studies suggest that 
adhesion at a distant site is a completely random process, while others have 
implicated the overexpression of adhesion molecules such as ICAM, E-Cadherin, 
or integrins [138,139]. Increased extracellular pressure promotes cancer cell 
adhesion in vitro by FAK and Src activation at the focal adhesion complex, Akt 
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activation, and ultimately increased β1 integrin binding affinity [100]. Shear stress 
similarly promotes adhesion in vitro [46]. These findings seem potentially 
clinically relevant, as cancer cells experience pressure and shear stresses as 
they circulate.   
 To test our hypothesis, CT-26 murine colon cancer cells were labeled with 
carboxyfluorescein succinimidyl ester (CFSE) and 1 million cells were injected 
into the tail vein of Balb/c mice. After 30 minutes, the cells were recovered by 
cardiac puncture and analyzed by flow cytometry. The flow cytometer gated only 
fluorescent CFSE labeled tumor cells that were further evaluated for FAK, Akt 
and 9EG7 phosphorylation or activation. Passage through the circulation 
increased phosphorylation of FAK at tyrosine 397 and Akt at serine 473, similar 
to that observed in vitro in response to increased extracellular pressure. 
Activation of the 9EG7 epitope, which specifically indicates activation of β1 
heterodimers, was also increased in cells recovered from the circulation (Figure 
37, n=6;p<0.05). Pretreatment with pharmacologic inhibitors to FAK or Akt 
prevented the increased phosphorylation of these molecules (not shown).   
 Pressures of the portal circulation are much lower (5-10mmHg) than those 
of the peripheral circulation (120-125mmHg) [140,141]. We first sought to 
determine whether pre-treating cells with pressure before injection into the portal 
circulation could increase adhesion and metastatic capability from within blood 
vessels. We exposed luciferase tagged CT-26 cells to ambient or 15 mmHg  
 
 
96 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 37.  Pressures of the systemic circulation activate signaling in 
circulating cancer cells.  Effect of circulatory pressures on β1 integrin 
heterodimer 9EG7 activation, FAK tyrosine 397 phosphorylation and Akt serine 
473 phosphorylation.  Data from individual experiments were normalized to their 
individual control.  MFI, mean fluorescent intensity.   
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Kodak IS4000MM small animal imaging device. Exposure conditions were held 
constant for all measurements and all bioluminescence intensity of the images 
were pseudocolored (pink-low intensity; red-highest intensity). Quantitation using 
MetaMorph software indicated a 73±6% increase in luminescence in the spleen 
and liver of mice injected with pressure pre-treated cells relative to ambient 
controls (Figure 38, n=16; p<0.05). Splenic weight increased 62±9% and hepatic 
weight 41±11% in mice receiving pressure pre-treated cells (Figure 39, 
n=16;p<0.05), and long term survival was substantially decreased in mice 
injected with pressure pre-treated cells compared with mice injected with cells 
not first exposed to increased pressure (Figure 40, n=20; p<0.05). Prior 
treatment of the cells with inhibitors of FAK or Akt before pressure treatment and 
splenic injection resulted in reduced luminescence in mice receiving cells not 
exposed to increased pressure and blocked the increase in luminescence 
associated with injection with pressure-treated cells (Figure 41). Furthermore, 
long term survival increased substantially in mice receiving inhibitor-treated, with 
or without pressure pre-treatment (n=20 for each inhibitor; p<0.05, Figure 40).  
To distinguish alterations in adhesion from any effect of this single dose of each 
inhibitor on cellular proliferation, we performed MTT assays on cells treated with 
the FAK or Akt inhibitor. We observed an initial decrease in cell proliferation with 
each inhibitor, but a full recovery in proliferation by 24 hours compared with 
untreated cells (Figure 42, n=5;p<0.05). Since we imaged the mice seven days  
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Figure 38.  15 mmHg increased pressure stimulates local metastasis via 
splenic injection.  Splenic and hepatic tumor burden was visualized using 
luminescence following splenic injection with ambient or pressure pre-treated 
luciferase tagged CT-26 cells.   
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Figure 39.  Splenic and hepatic weights following splenic injection.  Splenic 
and hepatic weights were measured following splenic injection with ambient or 
pressure pre-treated CT-26 cells.  Cardiac weight was used as a control.     
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Figure 40.  Long term survival following CT-26 splenic injection.  Long term 
survival was measured in mice following splenic injection of CT-26 cells pre-
treated with ambient or pressure conditions, or CT-26 cells pre-treated with FAK 
or Akt inhibitors prior to exposure to ambient or increased pressure conditions (* 
indicates p<0.05; ** indicates p<0.01).   
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Figure 41.  Splenic and hepatic burden following FAK or Akt inhibition.  
Splenic and hepatic tumor burden was visualized using luminescence following 
splenic injection of CT-26 cells pre-treated with FAK or Akt inhibitors prior to 
exposure to increased or ambient pressure.   
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Figure 42.  Cellular proliferation following treatment with FAK or Akt 
inhibitors.  An MTT assay was performed on CT-26 cells following treatment 
with FAK or Akt inhibitors (* indicates p<0.05; ** indicates p<0.01).   
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after surgery, our findings are thus more likely to reflect modulation of initial 
tumor cell adhesion than interference with cellular proliferation.   
 To further confirm that cancer cells become activated during transit 
through the circulation, we exposed luciferase tagged CT-26 cells to ambient or 
15 mmHg increased pressure for 30 minutes and injected 1 million into the tail 
vein of Balb/c mice. Seven days after surgery the mice were injected with 
luciferin and bioluminescent imaging was performed. In contrast to our results 
with portal injection, we observed no increase in lung metastasis in mice 
receiving pressure pre-treated cells relative to those receiving control cells 
preincubated at ambient (Figure 43, n=20) and we found no difference in long 
term survival (Figure 44, n=20), consistent with our observation (Figure 37) that 
the force-activated pathway was already activated by passage through the 
circulation. When we pre-treated the cells with FAK or Akt inhibitors to block this 
pathway, lung metastasis was reduced (Figure 45, n=12) and long term survival 
increased (figure 44, n=12).   
 Cancer metastasis is a complex process. Increased expression of cell 
surface receptors such as VEGF, loss of function of tumor suppressor genes 
such as p53 and over-expression of oncogenes all contribute [142]. Our results 
suggest that the extracellular forces experienced by cancer cells during 
circulation activate an adhesiogenic pathway that promotes adhesion and 
subsequent metastasis. Cells pretreated with increased pressure displayed 
increased adhesion and tumor burden locally, as illustrated by our splenic 
injection model. However, because pressure activation is already maximized as  
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Figure 43.  Metastasis of circulating tumor cells.  Lung metastasis following 
tail vein injection of CT-26 cells exposed to 15 mmHg increased or ambient 
pressure.   
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Figure 44.  Long term survival following CT-26 tail vein injections.  Long 
term survival of mice following tail vein injection of CT-26 cells pre-treated with 
15mmHg increased or ambient pressure, or pre-treated with FAK or Akt 
inhibitors.   
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Figure 45.  Lung metastasis following tail vein injection of inhibitor treated 
or untreated cells.  Lung metastasis was reduced following treatment with FAK 
or Akt inhibitors.   
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cancer cells travel through the circulation, pretreatment with pressure did not 
further increase lung metastasis in our tail vein model.    
 Previous studies have confirmed the importance of FAK and Akt activation 
in pressure induced signaling in vitro, as well the necessity of a dynamically 
functional cytoskeleton [100]. FAK is a critical regulator in the signaling by which 
pressure stimulates adhesion, proliferation and migration of cancer cells. In vitro 
studies suggest that increased pressure results in FAK phosphorylation and 
activation and downstream signaling. Furthermore, FAK and Akt may participate 
in bi-directional signaling where FAK is necessary for Akt activation and Akt is 
necessary for FAK activation. Upon activation, FAK and Akt translocate to the 
cell membrane where FAK associates with β1 integrin. This association 
increases in response to elevated pressures leading to increased integrin affinity 
[100,136].  Although this novel mechanism has been previously elucidated in 
vitro, this is the first demonstration that physical forces promote metastasis in 
vivo, and that interruption of the force-activated signal pathway has biological 
consequences for metastasis.   
 In the present study, pretreatment of the cancer cells with a single dose of 
an inhibitor of FAK or Akt, critical kinases activated by physical forces, decreased 
metastasis and increased long term survival. FAK or Akt expression is increased 
in diverse tumors, including those of colon, breast, prostate and lung [143,144]. 
Increased FAK expression correlates with increased cancer cell migration, 
invasion, and metastasis [144,145]. Akt stimulates aerobic respiration in cancer 
cells [146]. Akt activation and localization correlates with tumor invasion, 
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oncogene expression and an overall poor prognosis in several cancers, including 
thyroid, lung and endometrial [147]. Early stage clinical trials of chronic therapy 
with FAK or Akt inhibitors have shown promise. TAE226 is a FAK inhibitor that 
inhibits cell proliferation and migration, induces apoptosis and inhibits cancer cell 
growth through inhibition of FAK tyrosine 397 phosphorylation. Another FAK 
inhibitor PF-562,271 inhibits FAK autophosphorylation and has lead to tumor 
regression or stable disease in ovarian cancer patients when taken daily [148]. 
Similarly, the Akt inhibitors KP372-1 and GSK690693 inhibit tumor cell growth 
and proliferation and induce apoptosis in a variety of cancers with daily treatment 
[149]. Although such trials imply a potential benefit of these new 
chemotherapeutic agents as part of a daily, long term regimen, our current 
results suggest that even a single perioperative dose of these inhibitors may 
interfere with perioperative tumor dissemination and metastasis when tumor cells 
are shed during surgery.   
 In conclusion, our results indicate that in vivo pressures modulate cancer 
cell adhesion and metastasis. Cancer cells traveling through the circulation 
experience phosphorylation of FAK and Akt leading to activation of signaling that 
induces adhesion. Increased adhesion at a distant site perpetuates the 
metastatic process and indicates a poor prognosis for patients. These findings 
may be particularly relevant, to patients with unresectable tumors or patients 
undergoing surgery in whom millions of cancer cells may be shed from a primary 
tumor prior to and during its removal.   
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CHAPTER 7 
Discussion 
 Molecular signaling events that mediate cancer cell adhesion and 
proliferation are clinically relevant and necessary for our understanding of the 
metastatic process as well as inside out signaling.  These results demonstrate 
that pressure activation of cancer cells influences tumor cell adhesion, and by a 
different mechanism, cellular proliferation.  Furthermore, our results demonstrate 
the effect of pressure in vivo and potential targets to reduce metastatic events.   
 We have shown that pressure induces adhesion in colon and breast 
cancer cells.  Colon cancer cell adhesion is dependent upon paxillin 
phosphorylation at tyrosines 31 and 118. Phosphorylation at these sites activates 
a signaling cascade inducing Rac1.  Further evidence suggests paxillin signaling 
involves alpha-actinin, FAK and Src, and illustrates at least a partial working 
model by which physical forces may be translated into biochemical signals 
modulating integrin activation and cell adhesion.   
 In addition, our findings demonstrate the diverse pathway by which 
pressure induces cancer cell proliferation.  Previous studies from our laboratory 
have shown that pressure stimulated adhesion is dependent upon Src, Akt and 
an intact cytoskeleton, however, pharmacological disruption of these molecules 
had no effect on pressure induced proliferation.  Our current study elucidated a 
pathway by which pressure activates NF-kB, increasing transcription factor 
activity and proliferation.  Furthermore, immunohistochemical staining confirmed 
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increased NF-kB staining intensities in the high pressure center of human tumors 
relative to the periphery.   
 Finally, we have shown the effect of pressure in vivo using a local and 
systemic metastasis model.  Our findings confirm that cancer cell activation 
occurs as cells experience pressure changes while traveling through the 
circulation.  Disruption of the signaling that mediates pressure stimulated 
adhesion was shown to reduce tumor burden and increase long term survival.   
 Taken together, these results indicate two diverse signaling mechanisms 
by which pressure mediates adhesion as well as proliferation.  Elucidation of the 
final kinases regulating these mechanical signaling pathways, as well as 
redundancies within the pathways, may provide additional targets for therapeutic 
intervention, and thus merits further study.  Although we have found that NF-kB 
is not necessary for pressure-induced adhesion, we have yet to determine its 
relevance in vivo.  In addition, further investigation is needed to evaluate the role 
of calcium in this mechanical signaling study, as calcium dependent protein 
kinase C seems to be necessary for pressure-induced proliferation, but not 
calcium independent isoforms.  Full elucidation of this pathway may provide 
molecular targets to inhibit metastasis in disseminated tumor cells following 
curative tumor resection surgery and potentially improve overall survival.   
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 Increased extracellular pressure stimulates cancer cell adhesion by a 
mechanism that is dependent upon β1-integrin activation, an intact cytoskeleton, 
and FAK and Src activation.  By a different mechanism, increased extracellular 
pressure modulates cancer cell proliferation in a manner that is regulated by 
protein kinase C, but not Src or an intact cytoskeleton.  Previous studies from our 
laboratory have shown that paxillin is a necessary mediator in the pathway by 
which pressure stimulates adhesion; however, it had not been determined 
whether paxillin acts simply as a scaffold, or participates in diverse signaling 
events.  I therefore hypothesized that paxillin phosphorylation mediates pressure 
stimulated adhesion and further asked whether the independent pathway by 
which pressure induces proliferation is modulated by NF-kB.  Finally, I postulated 
that increased pressures of the circulation activate cancer cells to increase 
adhesion, proliferation and overall tumor burden in vivo.  My data illustrate that 
paxillin phosphorylation at tyrosines 31 and 118 is necessary for pressure 
stimulated adhesion, but tyrosine 81 phosphorylation is not.  The phosphorylation 
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events at tyrosine 31 and 118 form a docking site for the adaptor molecule Crk, 
which has a binding site for the highly phosphorylated molecule Cas.  Each 
member of the paxillin/Crk/Cas complex is necessary for pressure stimulated 
adhesion.  Furthermore, this complex promotes the activation of the small 
GTPase, Rac1.   
 Next, I evaluated whether Rac1 was necessary for pressure induced 
proliferation, and found that it is not.  However, it was found that this pathway is 
dependent upon NF-kB activation.  Increased extracellular pressure increases 
NF-kB activation in colon, breast and prostate cancer cells.  This increase is 
abolished in the presence of NF-kB inhibitors.  Further studies showed that 
increased pressure activates protein kinase C α/β, increases IKK and IkB 
phosphorylation, cyclin D1 expression and increased S-phase fractions.  
Immunohistochemical staining for NF-kB, IkB and cyclin D1 increased in the high 
pressure center of human tumors and decreased toward the periphery.   
 Finally, I determined that increased pressures of the circulation activate 
cancer cells in vivo by phosphorylation of β1 integrin, FAK and Src.  Pre-
treatment with pressure prior to systemic injection did not increase metastasis.  
However, in a local metastasis model, increased tumor burden and decreased 
long term survival occurred when cells were pre-treated with pressure.  These 
increases were abolished when cells were pre-treated with FAK or Akt inhibitors 
prior to injection.   
 In summary, my data suggests pressure activation of malignant cells 
promotes tumor development and impairs tumor free survival.  Preoperative 
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inhibition of paxillin, NF-kB, or other interventions aimed at blocking pressure-
induced integrin activation may abolish this effect.   
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